Protective Role of Palmitoleate against Zika Virus-Induced Apoptosis in Placental Trophoblasts by Muthuraj, Philma Glora
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Public Access Theses, Dissertations, and 
Student Research from the College of 
Education and Human Sciences 
Education and Human Sciences, College of 
(CEHS) 
7-2021 
Protective Role of Palmitoleate against Zika Virus-Induced 
Apoptosis in Placental Trophoblasts 
Philma Glora Muthuraj 
University of Nebraska-Lincoln, philma@huskers.unl.edu 
Follow this and additional works at: https://digitalcommons.unl.edu/cehsdiss 
 Part of the Nutrition Commons, and the Virology Commons 
Muthuraj, Philma Glora, "Protective Role of Palmitoleate against Zika Virus-Induced Apoptosis in Placental 
Trophoblasts" (2021). Public Access Theses, Dissertations, and Student Research from the College of 
Education and Human Sciences. 396. 
https://digitalcommons.unl.edu/cehsdiss/396 
This Article is brought to you for free and open access by the Education and Human Sciences, College of (CEHS) at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Public Access Theses, 
Dissertations, and Student Research from the College of Education and Human Sciences by an authorized 
administrator of DigitalCommons@University of Nebraska - Lincoln. 
PROTECTIVE ROLE OF PALMITOLEATE AGAINST ZIKA VIRUS-INDUCED 
APOPTOSIS IN PLACENTAL TROPHOBLASTS 
 
by 





Presented to the Faculty of  
The Graduate College at the University of Nebraska 
In Partial Fulfillment of Requirements  













PROTECTIVE ROLE OF PALMITOLEATE AGAINST ZIKA VIRUS-INDUCED 
APOPTOSIS IN PLACENTAL TROPHOBLASTS 
Philma Glora Muthuraj, Ph.D. 
University of Nebraska, 2021 
 
Adviser: Sathish Kumar Natarajan 
Zika virus (ZIKV) infection in pregnant women causes congenital Zika syndrome which 
involves birth defects such as intrauterine growth restriction (IUGR), retinal defects and 
microcephaly in the fetus. ZIKV infection results in placental pathology which plays a 
crucial role in disease transmission from mother to fetus.  Currently, there is no Food and 
Drug Administration (FDA) approved vaccine or therapeutic drug against ZIKV. In this 
thesis, we have elucidated the cell signaling pathways connected to ZIKV-induced 
apoptosis in trophoblasts and also the protective effect of palmitoleate against ZIKV-
induced apoptosis. First, we demonstrated the molecular mechanism behind ZIKV-
induced apoptosis using an in vitro model with JEG-3, JAR and HTR-8 cells. We found 
that persistent endoplasmic reticulum stress (ER stress) causes activation of c-Jun N-
terminal kinase (JNK), a stress kinase that leads to trophoblast apoptosis. Next, we 
studied the protective role of the nutrient compound palmitoleate, an omega-7 
monounsaturated fatty acid, in ZIKV infected trophoblasts. Palmitoleate has been shown 
to have lipokine activity and significant positive effects on metabolism. Palmitoleate 
treatment post-infection showed a significant decrease in the percentage of apoptotic 
nuclei and caspase 3/7 activity when compared to ZIKV-infected cells without 




notable decrease in viral load in palmitoleate-treated cells. To substantiate the protective 
role of palmitoleate against ZIKV-induced apoptosis, we treated trophoblasts with 
palmitate, a 16-carbon saturated fatty acid. Interestingly, we observed that palmitate did 
not show any protection against ZIKV-induced ER stress and apoptosis. In contrast, 
palmitoleate treatment enhanced survivability coupled with a non-significant reduction in 
plaque-forming units/mL of cell culture supernatant. Further, we observed high lipid 
droplet accumulation along with a significant reduction in IL-1β expression with 
palmitoleate treatment in infected cells. In conclusion, palmitoleate treatment is 
protective against ZIKV-induced ER stress and apoptosis in trophoblasts. Palmitoleate 
can be used as a nutrient compound to prevent placental pathology in ZIKV infected 
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CHAPTER 1: LITERATURE REVIEW 
 
1.1 Introduction 
Zika virus (ZIKV) is a Flavivirus from the Flaviviridae family (1). ZIKV is a positive-
sense RNA virus belonging to group IV in the Baltimore system of virus classification 
(2). It is an arbovirus (vector-borne virus) closely related to viruses like Dengue virus, 
yellow fever virus, West Nile virus, Japanese encephalitis virus, tick-borne encephalitis 
virus and chikungunya virus (2-4). ZIKV infection can be compared to pathogens such as 
toxoplasmosis, Rubella, Cytomegalovirus, and Herpes simplex viruses type 1 and 2, all of 
which cause a mild infection in the mother and is vertically transmitted to the developing 
fetus, causing congenital anomalies (5). 
ZIKV was first isolated from a sentinel monkey kept for studying mosquito-borne 
diseases, and it was also later isolated from Aedes africanus mosquitoes, confirming its 
vector-borne transmission in the Zika Forest of Uganda (6). Intracerebral inoculations of 
ZIKV in young mice showed extensive neurological lesions, while inoculation from the 
mice to non-human primates resulted in a self-limiting febrile condition in a few 
members. Later, neutralizing antibodies were found in both humans and monkeys on 
serological screenings (7). The first human case was reported during the isolation process 
of the virus, wherein the clinical signs were described as pyrexia along with rashes by 
Simpson in 1964 (8).  The disease was relatively insignificant with sporadic outbreaks in 




Zika virus (ZIKV) was considered a public health emergency by World Health 
Organization (WHO) in 2015 after the disease started to have a widespread outbreak 
across different continents around the globe (10). The occurrence of neurological 
abnormalities, especially in newborn infants, created a lot of concern regarding this 
disease outbreak (11). 
1.2 ZIKV epidemiology 
Until April 2007, there were very few cases of ZIKV infection reported in humans(12).  
The first widespread cluster of ZIKV outbreaks was reported from Yap island in 
Micronesia (13). Around 2013-2014, another outbreak with a considerable number of 
infections occurred in French Polynesia (14). Reports of various modes of transmission 
other than mosquitoes and involvement of neurological disorders such as Guillain-Barre 
syndrome in a subset of the population were observed during this outbreak (15,16). Later 
from 2014 onwards, places such as New Caledonia, Cook Islands, Easter Island, Anuatu, 
Solomon Islands, Samoa, and Fiji experienced ZIKV outbreaks (16). The presence of 
vectors and travel-related introductions of ZIKV to a population without any prior 
exposure, along with other existing arboviral infections like dengue and Chikungunya, 
may have favored the transmission of disease at a higher altitude (17-20). In 2015 ZIKV 
had spread to Brazil, and several hypotheses suggested that the spread could be due to 
travel associated with big events such as the soccer World Cup and other tournaments 
(21). Later, ZIKV spread to other parts of the American continent including Colombia, 
Honduras, Puerto Rico, the Dominican Republic, Jamaica, and Haiti (22). In the 




Florida in 2016 (23). In Asia, outbreaks were seen in Vietnam, Singapore, Philippines 
and Thailand (24). As the ZIKV cases began to decline the public health emergency 
declared by WHO was brought to an end in late 2016 (25). 
1.3 ZIKV Strains 
Genetic changes in the ZIKV, involving complex interactions between the vector, human 
populations and non-human primate populations led to the evolution of the virus (26). 
Two lineages of ZIKV are 1)Asian origin and 2)African origin. The African strain has 
two groups, the Ugandan versus the Nigerian group. The strain originally isolated from 
Rhesus macaque in the Zika forest is MR-766. Whereas IbH is the first strain isolated 
from the human blood in Nigeria (27). The first isolated Asian ZIKV strain is from 
Malaysia with the prototype strain P6-740, and the cluster includes strains from 
Cambodia, French Polynesia and other Asian countries. In contrast, some reports describe 
that the African strain lyses the placental cells more effectively than Asian strains but has 
the same replicative efficiency (28).  
ZIKV strains in the American continent that circulated from the 2015 Brazil outbreak, 
evolved from the Asian lineage (29). Travel-related to major sports events have mainly 
contributed to the spread of the virus from Pacific islands including French Polynesia to 
Brazil (30). The presence of a new glycosylation motif in an asparagine residue at 
position 154 of envelope protein in the 2007 Yap strain- EC Yap and the French 
Polynesian H/PF/2013 strain could explain the gain in their virulence when compared to 





1.4 Transmission of ZIKV 
Usually, the disease is spread by the bite of the infected mosquito (Aedes aegypti, Aedes 
albopictus)(32). Aedes mosquito larvae and pupae can get infected in sewage or water 
contaminated with urine from an infected person with low ZIKV concentrations(33). The 
infection can be vertically transmitted from infected mother to fetus. It can also be 
sexually transmitted, as ZIKV RNA is detected in semen samples of infected patients 
(34,35). Although around 3% of the total ZIKV cases account for sexually transmitted 
cases, a study suggests that semen suppresses the binding of ZIKV to cells(36). Blood 
transfusions from infected individuals could also be a potential source of infection. (37). 
The virus replicates in the epithelial cells of the mosquitoes’ gut and later spreads to the 
mosquitoes’ salivary gland: then, the virus spreads to humans during a mosquito bite 
(38,39). The receptors in the dermal fibroblasts, immature dendritic cells and 
keratinocytes facilitate viral entry and support viral replication (40). Wild macaques are 
naturally susceptible to ZIKV infection (41). The arbovirus infection follows a sylvatic 
cycle with non-human primates as the reservoir of the virus (42). They serve as the 
connecting bridge for ZIKV circulation among the mosquitoes and transmission to 
humans due to the extensive urbanization in the present-day scenario (43).  
1.5 ZIKV structure 
ZIKV is icosahedral in symmetry, ~40 nm with a nucleocapsid ~25-30 nm and surface 
projections ~5-10 nm (44,45). Its genome is 10.8Kb with 5' NCR (translation via a 
methylated nucleotide cap or a genome-linked protein) and 3' NCR (translation, RNA 
packaging, cyclization, genome stabilization, and recognition)(46-48). The virion consists 




NS1 for virion production, NS3, and NS5are large, highly-conserved proteins, NS2A, 
NS2B, NS4A, and NS4B are small, hydrophobic proteins and NS4B, NS5 are targets for 
evolution(48-50). Functions of individual ZIKV proteins are enlisted in the table below. 
Table 1.1 ZIKV viral proteins  
Protein  Function 
Envelope Host cell binding and membrane fusion (51) 
Capsid Viral protein surrounds nucleic acid (52) 
Membrane 
protein 
Proteolytic cleavage of a pre membrane protein from 
membrane protein in the Golgi apparatus results in the 
release of the virus (53) 
NS1 RNA replication (54) 
NS2A Modulates different components of the virus during assembly 
(55) 
NS2B Cofactor of NS3 protease (56) 
NS3 Protease and helicase domain for polyprotein possessing & 
nucleoside triphosphtase (NTPase)/ RNA triphosphatase 
(RTPase) activities (56) 
NS4A  Evasion of the innate immune response, associated with 
replication complex (57,58) 
NS4B Evasion of the innate immune response (59) 





1.6 ZIKV replication 
Virus entry into the cell occurs by the initial recognition of host receptors by glycosylated 
regions on the envelope protein of the ZIKV (61). Endocytosis of the infectious viral 
particle occurs by clathrin-coated vesicles. A low pH environment within the endosome 
facilitates conformational changes in the envelope protein of the virus, resulting in fusion 
to the endosome and thereby releasing the positive-strand RNA of the virus (62). The 
positive-strand gets translated in the endoplasmic reticulum of the host cells into a 
polyprotein that gets cleaved by the host cell proteases and the viral non-structural 
proteins such as NS3 and NS2B which is a co-factor for protease. Non-structural proteins 
NS5 (RNA-dependent RNA polymerase), NS3 (helicase) also replicate the positive-sense 
RNA strand to form a negative-sense RNA strand(63). The negative-sense RNA strand 
serves as a template for further production of a new positive sense RNA strand. The 
newly produced positive sense RNA strand can either be translated or further used for 
viral genome replication (64).  After the assembly of structural proteins around the viral 
genome, they are translocated to the Golgi apparatus where they become mature virion by 
cleavage of the precursor membrane protein and exit the host cell (65). 
1.7 Clinical findings and Congenital Zika Syndrome 
In normal healthy children and adults, ZIKV infection usually presents a mild febrile 
disease with rashes and joint pain (3). Other clinical signs may include diarrhea, cough, 
lymphadenopathy and photophobia (66). Pregnant women typically develop symptoms 
like rashes during ZIKV infection (67). ZIKV infection in pregnant women results in 
both congenital brain and ocular defects in the fetus. Brain defects include microcephaly, 




(68). Ocular defects include microphthalmia, optic nerve defects, cataract and intraocular 
calcifications. Congenital contractures, reduced musculoskeletal movements, dysphagia, 
hypertonia, hypotonia, seizures and irritability are also reported in infants with in utero 
ZIKV infection (69). Further, a case-control study showed that women with ZIKV 
infection during the early stages of pregnancy were more likely to have babies with 
congenital Zika syndrome (CZS) (70). ZIKV infection is also associated with the 
development of Guillain-Barre syndrome in some adults which is an autoimmune 
condition affecting the nervous system (71). 
1.8 Diagnosis, treatment and prevention of ZIKV infection 
In suspected ZIKV cases, a diagnosis is usually based on laboratory confirmation using 
IgM detecting serological test or RT-PCR based on E and NS2B genes (72-74). In a 
particular place when there are ongoing outbreaks, it is recommended for pregnant 
women to get tested for ZIKV infection (75). Serology tests can detect ZIKV as early as 
one week after suspected infection, but cross-reacting antibodies from other Flaviviruses 
can result in false-positive serological results (76). RT-PCR can be used to detect the 
disease during initial viremia in urine samples, cord blood and placental samples (77). 
Currently, there is no approved vaccine for the effective prevention of the disease (78). 
Only supportive treatment is available if infected(79). Implementing effective mosquito 
control strategies in places with ZIKV infection is crucial to break the chain of ongoing 
disease spread (80). Avoiding travel to areas with ongoing ZIKV outbreaks, especially if 
pregnant or planning to get pregnant are some of the ways to reduce the risk of infection 




population of wild type mosquitoes to control mosquito-borne disease exists yet it is 
considered an emerging risk (82) 
1.9 ZIKV vaccines and drug development 
ZIKV vaccine development is challenged by the target audience; it must be safe for 
pregnant women, to prevent neurological disorders in adults and fetuses (83,84). Despite 
the challenges, several vaccine candidates have entered preclinical animal studies and 
phase I clinical trials. Some of the vaccine candidates which have entered phase I clinical 
trials that are noteworthy to mention include DNA vaccines by Inovio Pharmaceuticals 
and NIH, whole purified inactivated vaccine by WRAIR/Sanofi Pasteur Limited and 
Live, Dengue virus vectored vaccine by Butantan Institute (83). Another major issue in 
vaccine development and translation of the vaccine technology into use is that ZIKV 
outbreaks had waned, making it too challenging to test the effectiveness of the vaccine 
without ongoing active disease transmission, as well as the slow decline in funding, 
supports aiding in vaccine development (85). Several drug repurposing studies have been 
conducted and found to be effective against ZIKV infection. However, there are no FDA-
approved drugs available for ZIKV infection because most of the drugs don’t have 
enough data to support safety in pregnant women (85). Few examples of already existing 
drugs with anti-ZIKV activity are suramin, nitazoxanide, chloroquine (anti-protozoal 
drugs), niclosamide, ivermectin (anthelmintics), mycophenolic acid (an 
immunosuppressant drug), PHA-690509 (cyclin-dependent kinase inhibitor) and 
sofosbuvir (an anti-viral drug effective against hepatitis C virus, (86). Sofosbuvir has 
shown promising results in preventing ZIKV transmission from mother to fetus in 




1.10 Nutraceuticals against ZIKV infection 
Nutraceuticals are naturally occurring compounds in food with health or medicinal value 
(89).  In an insilco analysis, around 2263 plant-derived compounds were screened and 43 
of those compounds had anti-viral potential against ZIKV. Some of the well-known 
plant-derived compounds which could bind to ZIKV proteins are kanzonol V from 
licorice root (Glycyrrhiza glabra), cinnamoylechinaxanthol from Echinacea root; 
cimiphenol from black cohosh (Cimicifuga racemosa), rosemarinic acid from rosemary 
(Rosmarinus officinalis), lemon balm (Melissa officinalis), and common sage (Salvia 
officinalis) (90). Isoquercitrin, which is a flavonoid compound, has been found to 
interfere with the entry of the virion into the target cells (91). Curcumin, a bioactive 
compound in turmeric also prevents ZIKV attachment to cells (92). Gossypol, a phenolic 
compound seen in cotton seeds, has anti-ZIKV activity by interacting with the envelope 
protein domain III of the virus (93). F-6 and FAc-2 fractions abundant with cyclic 
diterpenes with aldehyde groups from Dictyota menstrualis, a brown seaweed in Brazil, 
have potent anti-viral activity against ZIKV (94). Polyphenols such as delphinidin and 
epigallocatechin gallate, which are available in natural products such as wine and tea, 
exhibited antiviral activity against ZIKV in an in-vitro model (95). Berberine, an 
isoquinoline alkaloid seen in Berberis vulgaris, as well as Emodin, an anthraquinone 
derivative available in Rheum palmatum, Polygonum multiflorum, Aloe vera, and Cassia 
obtusifolia  were found to have anti-viral activity against ZIKV (96). A flavonoid 
compound called naringenin seen in citrus plants exhibits anti-ZIKV activity by binding 
to the protease domain of the NS2B-NS3 protein (97). 6-deoxyglucose-diphyllin, seen in 




lysosome or endosome that allows the virus to fuse. Further, 6-deoxyglucose-diphyllin 
also was protective against ZIKV infection both in cell culture as well as in an 
immunocompromised mice model (98). Hippeastrine hydrobromide seen in Lycoris 
radiate was found to be protective against the neuronal damage caused by ZIKV along 
with having other anti-viral activity (99). Doratoxylon apetalum plant extract, which is 
already known to have a protective role against oxidative stress in cells, also had anti-
viral activity by preventing ZIKV entry into the cells (100). 25-hydroxy cholesterol seen 
naturally in the hosts was found to have anti-viral activity and was able to prevent ZIKV 
associated clinical signs in both mice and macaque models. Similarly, 25-hydroxy 
cholesterol also inhibited ZIKV infection in human corticoid organs and microcephaly in 
newborn mice pups (101). Omega-3 polyunsaturated fatty acid, docosahexaenoic acid 
(DHA) was found to have a protective effect against ZIKV-induced neuronal damage in a 
cell culture model (102). Nutraceuticals investigated for anti-ZIKV activity enlisted in the 
table below: 
Table 1.2 Natural compounds effective against ZIKV infection 
 












1.11 Nutrition and ZIKV 
The nutritional status of the host can contribute to the evolution of the viral disease by 
mutations contributing to virulence (105). Likewise, the nutritional status of the host can 
also play a role in the vector-borne disease evolution (106). Evidence of supportive 
nutritional therapy has been important in arboviral infections like dengue, but there are 
very limited reports surrounding the topic of nutritional parameters in the context of 
ZIKV infection (107). There is an interesting hypothesis which states that the neuronal 
damage associated with ZIKV could result from the retinoid compounds that have leaked 
from the liver tissue during ZIKV infection (108). A study found an association between 
nutrition and motor function in children with palpsy; this could also possibly affect the 
outcomes in infants affected with ZIKV infection (109). A correlation between ZIKV 
infection and anemia has been seen in several cases, and in contrast, other reports show 
no evidence of anemia with ZIKV infection (110,111). A study using a mice model 
revealed that protein malnutrition could be a risk factor to develop congenital Zika 
Polyphenols - delphinidin and 
epigallocatechin gallate 
(103) 
Berberine  (104) 
Naringenin- flavonoid (97) 
6-deoxyglucose-diphyllin (98) 
Hippeastrine hydrobromide (99) 
Doratoxylon apetalum plant extract (100) 





syndrome. The results of this study are possibly correlated to the fact that undernutrition 
is commonly seen in regions with major Zika outbreaks such as Brazil (112). Another 
interesting entomology study found that blood meals containing ZIKV showed prominent 
infection in mosquitoes when compared to protein meals containing ZIKV fed 
mosquitoes (113).  A study showed that folic acid supplementation reduced ZIKV 
infection in a cell culture model associated with the placental barrier and showed 
improved postnatal outcomes in fetuses from ZIKV infected pregnant mice (114). 
Therefore, monitoring folic acid nutrient status in ZIKV prone endemic areas and 
enabling its supplementation could help to ameliorate the adverse effect on the fetus 
observed during ZIKV infection (114).  
1.12 Immunological response to ZIKV infection 
ZIKV can evade the innate immune responses generated by the host via suppression of 
type I interferon and the subsequent activation of interferon-stimulated genes via non-
structural viral proteins like NS5 and NS4A (57,115). Interferon λ is known to protect 
against ZIKV infection in females in cases of the sexual route of transmission (116). A 
recent study shows that at least a 12-month interval between an initial Dengue virus 
infection confers an effective cellular immune response against a subsequent ZIKV 
infection (117). There are also contrasting studies that report pre-existing antibodies 
against the Dengue virus aggravating ZIKV infection (118,119). Production of IgM, 
which is the first antibody to appear against the first encounter with a pathogen, is found 
to be affected in populations with pre-existing antibodies against flavivirus (120). Pre-
existing antibodies against ZIKV can also cause severe outcomes after subsequent 




Studies have shown that interferon λ could be protective against ZIKV infection in the 
placenta (123-125). On the other end, a recent study has shown that placental alkaline 
phosphatase stabilized by binding immunoglobulin protein (Bip) aids ZIKV infection in 
placental cells (126). ZIKV activates an inflammatory response following infection by 
inflammasome complex formation resulting in IL-1β release (127-129). The placenta 
undergoes extensive inflammatory changes following ZIKV infection with upregulation 
of cytokines like IFN-γ and TNF-α and chemokines like RANTES (regulated on 
activation, normal T cell expressed and secreted) and VEGFR-2 (vascular endothelial 
growth factor receptor-2) (130,131). Toll-like receptor-3 (TLR-3), which is a pattern 
recognition receptor of the innate immune system that senses double-stranded RNA 
which is seen during ZIKV replication, is involved in activation of the inflammatory 
response particularly in astrocytes (132). Similarly, babies with congenital Zika 
syndrome were found to be highly associated with single nuclear polymorphisms in TLR-
3 or TNF-α (tumor necrosis factor-alpha) alleles (133).  These studies allude to the 
importance of the inflammatory response in the ZIKV-induced pathological 
manifestations in the host. Another important component that protects against ZIKV 
infection is a cell-mediated immune response and its associated neutralizing antibody 
generation which is crucial for immunity. Meanwhile, immunologically privileged parts 
of the body like the gravid uterus might be vulnerable to ZIKV infection (134). A sero-
surveillance report in Fiji and French Polynesia of Pacific Islands that experienced ZIKV 
outbreaks in 2013-2014, currently displays a pattern wherein the younger population 
comprising of children still have neutralizing antibodies against ZIKV but the older 




ZIKV and inflammation: ZIKV is known to affect various organs in the body from the 
eyes to the reproductive organs. ZIKV especially strains from the Asian lineage, are 
known to produce an inflammatory response in the body (136). A study in chicken 
embryo livers showed that ZIKV from Asian lineage (isolated from China) elicited a very 
intense inflammatory response in comparison to dengue virus infection (137). ZIKV 
infection in non-pregnant mice caused acute inflammation of the ovaries without any 
long-term effects on the overall reproducing ability (138). An immunocompetent 
C57BL/6J mice model with intravenous challenge study also suggests that ZIKV induces 
an inflammatory environment in the blood-brain barrier. Additionally, ZIKV elicits a 
strong inflammatory response in human retinal epithelial cells, chemokine, CXCL10 was 
highly expressed following infection (139). There is also evidence of placentitis in 
pregnant women following ZIKV infection (131,140). Transcriptome analysis of human 
umbilical vein endothelial cells (HUVEC) showed upregulation of several cytokines, 
chemokines and matrix metalloproteinases on ZIKV infection (141). There are also cases 
of ZIKV-induced meningitis, encephalitis and myelitis in certain patients (142). In a 
recent study, IL-22 was attributed to inflammation of the brain in newborn mice pups 
infected with ZIKV(143). Mice models suggest that ZIKV can cause orchitis and 
epididymitis via pro-inflammatory cytokines and chemokines (144). Overall, ZIKV 
infection elicits an inflammatory response in the host. 
1.13 Cell death in ZIKV infection 
 ZIKV is known to initiate apoptosis, in which both intrinsic pathways and extrinsic 
pathways contribute to cell death in the neuronal progenitor cells, leading to 




death ligands like FasL while the activation of the intrinsic pathway is by cytochrome C 
released from damaged mitochondria. Both intrinsic and extrinsic pathways merge into a 
common pathway by activating effector caspases that triggers apoptosis also known as 
programmed cell death (147). Also, activation of the necroptotic pathway via 
RIPK1/RIPK3 (Receptor-interacting serine/threonine-protein kinase 1/3) and Z-DNA-
binding protein 1 (ZBP1) favors succinate dehydrogenase formation in neuronal cells 
which interfere with ZIKV replication was reported (148). Pyroptosis is also known to be 
associated with ZIKV infection by its activation of NLRP3 complex formation, which 
initiates caspase-1 activation (149,150). A recent study highlights the mechanism of 
pyroptosis in neuronal progenitor cells following ZIKV infection (151). ZIKV replicates, 
forming complexes inside the endoplasmic reticulum, resulting in large vacuoles in the 
cytoplasmic compartment of the cell and leads to paraptosis in human epithelial cell lines, 
human primary fibroblasts and astrocytes (152). Necrotic cell death involves swelling of 
internal cellular organelles, which eventually rupture and are released outside the cell 
(153). Necrotic lesions involving the brain are also observed in animal models including 
immunocompetent mice and non-human primates (154,155). Autophagy, once considered 
as a cell survival pathway by recycling cellular cargoes via lysosomes to build new 
cellular components, under certain conditions can activate cell death directly or indirectly 
(156). ZIKV causes extensive activation of autophagy by downregulating Akt-mTOR 
(Protein kinase B- Mammalian target of rapamycin) signaling pathways aiding in 
replication (157). In contrast, another study showed that activation of the mTOR pathway 




induces apoptosis, necrosis, pyroptosis, paraptosis and autophagy-dependent cell death 
pathways. 
1.14 ZIKV and placenta 
Structure and function of the placenta: The placenta is a temporary organ that develops 
between the fetus and the mother and participates in nutrient transport, waste exchange 
and metabolism (159). In humans, the fetal part of the placenta is composed of the 
placental disc, umbilical cord, amnion and chorion, whereas the maternal part from the 
endometrium of the uterus is the decidua (160). The major cell type that predominates in 
the placenta is the trophoblasts, which include syncytiotrophoblasts, villous 
cytotrophoblasts, and extravillous trophoblasts that are characterized by a highly invasive 
nature, supported by the maternal decidual cells (161). The placental functional units are 
called villi, formed by an outer layer of trophoblasts with a stromal core (162). The 
placental villi participate in nutrient absorption for the growing fetus like the intestinal 
villi that absorb nutrients from digested food in the gastrointestinal tract (163,164). 
Cytotrophoblasts are a layer of cells that cover the stromal core located between the 
basement membrane and syncytiotrophoblasts (165). Extravillous trophoblasts are cells 
that migrate from the villi and are involved in uterine remodeling by forming trophoblast 
cell columns. Syncytiotrophoblasts are multinucleated cells covering the entire placental 
units, 2-3 cytotrophoblasts fuse to form syncytiotrophoblasts (166,167). Both 
syncytiotrophoblasts and extravillous trophoblasts are differentiated from the 
cytotrophoblasts (168). The stromal core of the placenta is richly supplied with blood 
vessels that originate from the mesenchymal stem cells and Hofbauer cells (placental 




ZIKV infection in the placenta and its consequences: ZIKV has been demonstrated to 
replicate in the human placenta, including the Hofbauer cells and trophoblasts (169-172). 
T cell immunoglobulin and mucin domain 1 (TIM1), Tyro3 and Axl (tyrosine-protein 
kinase receptors) are considered the cofactors for viral entry into cells.  There is a 
considerable expression of TIM1 in cytotrophoblasts, fibroblasts, umbilical vein 
endothelial cells, Hofbauer cells and amniochorionic membranes of the placenta, whereas 
Tyro3 and Axl are variably expressed in these cells (173). The first trimester of 
pregnancy was reported to be most susceptible to ZIKV infection (70,140,174,175). 
While some reports demonstrated that congenital Zika virus syndrome was also observed 
with ZIKV infection during the second and the third trimesters of pregnancy (176-178). 
Placental enlargement is an early clinical feature noticed in ZIKV infected 
pregnancies(179).  Pregnant women who delivered babies with microcephaly typically 
exhibit clinical signs of ZIKV infection around the start of mid-gestation (8-16 weeks); 
this is when maternal blood circulation is well established via the placenta (180). 
Breaches in the placental barrier could be detected in placental sections from ZIKV 
infected women (181). A study using a cell culture model suggests that ZIKV can breach 
the placental barrier by disruption of tight junctions between the cells of the placenta. 
Further, ZIKV virions take a transcytosis route to enter the tightly regulated placental 
barrier and blood-brain barrier (182). Another study using placenta samples from ZIKV 
infected women infected reported that there are ongoing changes in the tight junctions of 
the syncytiotrophoblasts with the decrease in the claudin 4 expression that leads to 
potential breaches of the placental barrier (183). ZIKV could also be transferred from the 




ZIKV infection alters the lipid metabolism of placental cells by favoring lipid 
droplet deposition, which contributes to the ongoing inflammatory process coupled with 
mitochondrial dysfunction (131). Another study reported the association of sphingolipids 
and deposition of ceramides with ZIKV replication particularly in neuronal progenitor 
cells (185).  A study in ZIKV infected women showed that the placental samples had an 
inflammatory state even without the actual presence of ZIKV virion and also connects 
this to the involvement of a modulatory role of anti-inflammatory protein annexin 1 
(ANXA1) as a result of ZIKV exposure to the placenta (186). Further, the presence of 
non-neutralizing flavivirus antibodies was also shown to facilitate or enhance viral 
infection and spread to syncytiotrophoblasts via neonatal Fc gamma receptor (FcRn) 
(187). A  Recombination-activating gene-1(RAG-1) knockout mice treated with 
interferon α/β receptor (IFNAR 1) antibody study shows that neutrophils and 
macrophages of the dam can play an important role in limiting  ZIKV spread to the fetus 
(188). A recent study in twins found that trophoblasts from the baby without the 
congenital Zika syndrome had a differential activation of genes which contributed to its 
ability to mount a better immune response against the infection (189). Expression of 
Insulin-like growth factor II (IGF2), which is necessary for the proper development of the 
baby, was found to be inhibited in placental samples from ZIKV infected women (190). 
Researchers were even able to rescue ZIKV in vitro from mesenchymal stem cells 
derived from the placenta of a woman who had cleared the infection and delivered a baby 
negative for ZIKV infection alluding to ZIKV persistence (191).  
In a normal pregnancy, monocytes are polarized to the M2 state to be compatible 




immunosuppressive state with potential suppression of type I interferon response.  But 
monocytes are predominantly polarized to the M1 pro-inflammatory phenotype, resulting 
in adverse outcomes of pregnancy due to ZIKV African strain infection (196). The 
CD14+CD16+ monocytes in the peripheral circulation are also affected by ZIKV 
infection, producing a 100-fold increase in the expression of CXCL12 and IL-6 in ZIKV 
infected women (195). Further, the presence of non-neutralizing flavivirus antibodies was 
also shown to facilitate or enhance viral infection and spread to syncytiotrophoblasts via 
neonatal Fc gamma receptor (FcRn) (187). 
Animal models of ZIKV infection during pregnancy: A study of ZIKV infection in 
pregnant rhesus macaques confirmed extensive uteroplacental pathology leading to 
decreased oxygen permeability. This model recapitulates the adverse outcomes noticed in 
humans such as reduced intrauterine growth, and still-birth (192). Similarly, 
immunocompetent wild-type mice mated with immunocompromised (interferon α/β 
receptor knock-out (IFNAR -/-)) resulted in heterozygous pups which are 
immunocompetent exhibited extensive placental pathology and fetal damage following 
ZIKV infection (193,194). Further extensive placental labyrinth apoptosis contributing to 
hypoxia in the heterozygous fetus resulting in early resorption (194).  
1.15 Endoplasmic reticulum (ER) stress in ZIKV infection 
The ER is an important subcellular organelle in a eukaryotic cell wherein the oxidizing 
environment and chaperones serve the purpose of protein folding, and it also serves as the 
site for steroid hormone and lipid synthesis (197). Several conditions including hypoxia, 




misfolded proteins in the ER leading to ER stress. This in turn results in the activation of 
several interactive signaling pathways known as the unfolded protein response (UPR). 
During ER stress, cells can undergo two possible fates: cell survival and cell death. The 
UPR tries to remove the misfolded proteins in the ER using different pathways to help 
cell survival, but persistent or prolonged ER stress can overwhelm the protective 
mechanism that aids in cell survival, resulting in the activation of cell death pathways 
like apoptosis (198).  
There are 3 main arms of the UPR activation in cells with ER stress as shown in 
Figure1.1. Usually, these sensors of unfolded proteins are at an inactive monomeric state 
with the association of Bip. It dissociates with a loss of homeostasis between folded and 
unfolded proteins leading to activation of ER stress sensors: 1) protein kinase RNA like 
endoplasmic reticulum kinase (PERK), 2) inositol requiring enzyme 1 alpha (IRE1α) and 
3) activating transcription factor 6 (ATF6).  
Flaviviruses are closely associated with ER stress as they replicate within the cellular 
membrane-bound organelles especially the ER. Accumulation of structural and non-
structural proteins in the ER results in the formation of convoluted spherules which 
activates UPR. Apart from this, ZIKV also remodels the ER in terms of its protein and 
lipid content (199,200). The shift from direct to indirect neurogenesis is done by 
decreasing UPR activity. Any dysregulation in this response could lead to microcephaly. 
ZIKV infection in neuronal progenitor cells activates PERK and IRE1α signaling 
pathways, suggesting the molecular mechanism behind the cause of microcephaly (201). 
Further, ZIKV could indirectly activate UPR in response to ER stress by inducing 




attracts the resident macrophages (microglial cells), amplifying the response (202). ZIKV 
can also thwart the UPR mechanism by cells to counteract ER stress by downregulating 
Bip in A549 cells (human alveolar basal epithelial cell line) (203). 
Additionally, there is cross-talk between the pathways of these three arms. Activation of 
the PERK pathway inhibits global protein synthesis via the phosphorylation of eukaryotic 
initiation factor 2 (eIf2α). ZIKV infected neuronal cells also show activation of the PERK 
pathway involving phosphorylation of eIf2α and activation of other targets such as ATF4, 
ATF3 and CHAC1(glutathione-specific γ-glutamylcyclotransferase 1) (204,205).  
Activation of IRE1α which has endoribonuclease activity splices out a 26-nucleotide 
intron from X-box binding protein 1 (XBP1) resulting in a frameshift. This spliced XBP1 
is now a transcription factor and can translocate to the nucleus for the upregulation of 
UPR-related genes that are involved in protein folding and endoplasmic reticulum-
associated degradation pathways (ERAD) (206). ZIKV is known to activate the IRE1α 
arm including XBP1 gene splicing, ER degradation-enhancing α-mannosidase-like 1 
(EDEM-1) activation in neuronal cells (204). Activation of IRE1α and XBP1 gene-
splicing facilitates lipid droplet production via stearoyl coenzyme A desaturase 1 (SCD1) 
(207). ER stress also induces the activation of ATF6 and it gets translocated from the ER 
to the Golgi apparatus where it is processed to expose its cytoplasmic DNA binding 
domain. This fragment of ATF6 processed in the Golgi apparatus acts by upregulating the 
expression of UPR related genes that aid in protein folding (208). ATF6 is known to 
positively regulate XBP1 gene expression during UPR activation. Further, the ATF6 





Arms of the ER stress pathway 
 
 
Fig.1.1. Schematic representation of the three arms of ER stress and its downstream 
targets.  
Infection or starvation or hypoxia triggers unfolded protein accumulation in cells 
resulting in the activation and cross-talk among the three arms of ER stress leading to 
translation arrest, activation genes involved in protein folding and endoplasmic 
reticulum-associated degradation (ERAD). 
 
Though cell survival is the main goal of signals generated through the three arms of ER 
stress, alternatively, persistent or sustained ER stress can activate apoptotic pathways as 
described in Figure 1.2. ER, stress-induced apoptosis is regulated by C/EBP homologous 
protein (CHOP), c-Jun N-terminal kinase (JNK) and B-cell lymphoma 2 (Bcl-2) family 
of proteins giving way to the activation of caspases (209). All three arms can cause 
transcriptional activation of CHOP. CHOP acts mainly by the downregulation of anti-
apoptotic activity of Bcl-2 and also acts by upregulating other targets such as growth 
arrest and DNA damage-inducible gene 34 (GADD34), endoplasmic reticulum 
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oxidoreductin 1 alpha (ERO1α) and tribbles-related protein 3 (TRB3) (210-212). 
Activated JNK phosphorylates Bcl-2 and bim and results in the activation of bax and bak 
in the mitochondria, thereby initiating the intrinsic pathway of apoptosis (213). CHOP 
activation is also linked to ER stress and apoptosis in ZIKV infected neuronal cells (204). 
MAPK Kinases like JNK and p38 also play a critical role in the infection of flavivirus 
like dengue (214). Reticulophagy or ER-phagy cooperatively works with UPR to restore 
homeostasis in the ER membranes, but ZIKV can suppress this reticulophagy by reducing 
Family with Sequence Similarity 134 Member B (FAM134B) (215). 
The cellular fate: undergoing ER stress 
 
Fig.1.2. Schematic representation of pathways that leads the cell to progress from 
ER stress towards apoptosis.  
ER stress in cells over some time results in activation of CHOP and JNK which drives the 
cells to undergo apoptosis by the activation of terminal caspases. Altogether, ZIKV can 
infect the placenta resulting in vertical transmission to the fetus and the underlying 
molecular mechanism involves prolonged ER stress leading to apoptosis. 
1.16 Palmitoleate 
The need for safe treatment or control methods in ZIKV infected pregnant women to 
prevent adverse effects in the developing fetus paved the pathway to study the use of 
palmitoleate, a nutrient compound as a potential therapeutic agent against ZIKV. 
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Structure and Sources: Palmitoleate is an omega 7 monounsaturated fatty acid (16:1n‐7) 
with a double bond in the 7th carbon atom counting from the methyl group with a total of 
16 carbon atoms (216). It is found predominantly in adipose tissue and blood (217,218). 
Mammals can produce the cis form of palmitoleic acid synthesized from the saturated 
fatty acid palmitate via the stearoyl-CoA desaturase 1 enzyme (SCD1)(219). The trans-
form of palmitoleic acid can be obtained from the consumption of dairy products and 
meat with fat content (219-221). Next to oleate, palmitoleate is the second most abundant 
monounsaturated fatty acid in the body (221). Plant sources of palmitoleate are 
macadamia nuts (Macadamia integrifolia), seabuckthorn (Hippophae rhamnoides), 
Durian fruits (Durio graveolens) and blue-green algae (221,222). Macadamia nuts alone 
contains 15-22% of palmitoleate occurring in its cis form (222-225).  
Lipokine activity: Palmitoleate is a lipokine that can be released by fat tissue deposits, 
exerting functional roles in various organs (219). Palmitoleate released from fat tissue 
lysis during endurance exercise regimes is known to cause cardiomyocyte hypertrophy 
(226). Palmitoleate addition to bovine adipose tissue cultures promoted fatty acid 
oxidation and prevented lipogenesis (227). Similarly, systemic administration of 
palmitoleate reduced intramuscular fat deposition and improved insulin sensitivity in 
obese sheep (228). A macadamia nut-rich diet in humans has been shown to improve the 
lipid profile by decreasing low-density lipoprotein (LDL) (229,230). Supplementation of 
palmitoleate along with western diet in LDL receptor knock-out mice showed a 
significant reduction in the size of atherosclerotic plaques in the heart when compared to 
mice supplemented with high oleic acid olive oil or control mice fed with western diet 




endothelial cells (232). A cohort study involving people with different ethnic 
backgrounds in the USA found that high levels of circulating trans palmitoleate were 
correlated to a reduced risk of diabetes (220). Another cohort study in non-diabetic 
individuals also found a correlation between high levels of circulating palmitoleate and 
improved insulin sensitivity, as the palmitoleic acid can reduce fatty acid-induced 
damage which affects the beta cells of the pancreas and the glucose metabolism (233). 
Positive effects on metabolic health: Palmitoleate could change the polarization of 
macrophages from the inflammatory M1 macrophage seen in animals fed with an 
obesogenic diet to the anti-inflammatory M2 macrophage through activation of adenosine 
monophosphate-activated protein kinase (AMPK) (234). The overall health benefits from 
palmitoleate supplementation in reducing inflammation, insulin resistance and preventing 
cardiovascular diseases could be attributed to the activation of AMPK supporting energy 
generation rather than its utilization (235). Palmitoleate supplementation reduces the 
inflammation in high-fat diet-induced fatty liver conditions (236,237). Palmitoleate was 
found to promote lipolysis via hormone-sensitive lipase (HSL) and adipose triglyceride 
lipase (ATGL) activity in adipose tissue through peroxisome proliferator-activated 
receptor alpha (PPARα) activation (238,239). It was observed that the synthesis of 
palmitoleate was reduced in syncytiotrophoblasts isolated from obese mothers. This 
reduced palmitoleate production could aid in promoting an inflammatory environment 
and reduced insulin sensitivity in obese mothers (240). In a rodent, study palmitoleate 
was also found to augment the wound healing process, which could be due to its anti-
inflammatory property (241). Palmitoleate was found to release satiety hormone 




(242). Conversely, increased activity of the SCD1 enzyme that converts palmitic acid to 
palmitoleic acid results in insulin resistance, fatty liver and metabolic syndrome (243). 
Another study in male physicians observed that increased palmitoleate levels in the red 
blood cell (RBC) correlated to an increased risk of cardiovascular disease (244). When 
enveloped φ6 bacteriophages were treated with monounsaturated fatty acids such as 
palmitoleic acid and oleic acid, it resulted in inhibition of viral replication but saturated 
fatty acids like palmitic acid or myristic acid did not inhibit viral replication (245). 
Overall, palmitoleate has several arrays of functional roles in the body. 
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1.18 Central hypothesis and specific aims 
Central Hypothesis: It is known that ZIKV induces ER stress (Endoplasmic reticulum 
stress) in progenitor neuronal cells, a potential molecular mechanism behind 
microcephaly. Similarly, we also hypothesize that ZIKV- induced apoptosis in placental 
cells could be a downstream effect of sustained ER stress contributing to pathologies like 
IUGR and other obstetrical complications. Further, in our study, we try to address the 
protective role of palmitoleate against ZIKV-induced apoptosis in placental cells. 
Specific Aim 1: To examine ZIKV induces ER stress and apoptosis in the placental 
trophoblast. 
We hypothesize that ZIKV infection causes the activation of ER stress signaling pathway 
and activation of the apoptotic pathway in the placental trophoblast. We will be testing 
placental cells with ZIKV infection for activation of ER stress arms such as IRE1α and 
PERK and its downstream targets such as spliced forms of XBP1, phosphorylated eIF2α. 
We will also test the critical role of and activation ER stress in placental trophoblast 
apoptosis with ZIKV infection using small molecule inhibitors of ER stress like 
salubrinal. We will be testing other downstream targets that lead to apoptotic signals due 
to persistent ER stress such as CHOP and JNK activation.  
Specific Aim 2: To elucidate the protective role of palmitoleate against ZIKV-induced 
apoptosis in placental trophoblasts. 
We hypothesize that palmitoleate treatment protects against ZIKV-induced placental 
trophoblast apoptosis. We will test the protective role for palmitoleate supplementation 




HTR-8 cells. The protective role of palmitoleate could be lipid-based interaction with 







CHAPTER 2: ZIKA VIRUS INFECTION INDUCES ENDOPLASMIC 
RETICULUM STRESS AND APOPTOSIS IN PLACENTAL TROPHOBLASTS 
Muthuraj et al., Cell Death Discovery, 2021 Nov; 7(1):24 
(PMID:33500388) 
2.1 Abstract 
Zika virus (ZIKV) infection to a pregnant woman can be vertically transmitted to the 
fetus via the placenta leading to Congenital Zika syndrome. This is characterized by 
microcephaly, retinal defects and intrauterine growth retardation. ZIKV induces placental 
trophoblast apoptosis leading to severe abnormalities in the growth and development of 
the fetus. However, the molecular mechanism behind ZIKV-induced apoptosis in 
placental trophoblasts remains unclear. We hypothesize that ZIKV infection induces 
endoplasmic reticulum (ER) stress in the trophoblasts and sustained ER stress results in 
apoptosis. HTR-8(HTR-8/SVneo), a human normal immortalized trophoblast cell and 
human choriocarcinoma derived cell lines (JEG-3 and JAR) were infected with ZIKV. 
Biochemical and structural markers of apoptosis like caspase 3/7 activity and percent 
apoptotic nuclear morphological changes, respectively were assessed. ZIKV infection in 
placental trophoblasts showed an increase in the levels of CHOP mRNA and protein 
expression which is an inducer of apoptosis. Next, we also observed increased levels of 
ER stress markers such as phosphorylated forms of inositol-requiring transmembrane 
kinase/endoribonuclease 1α (P-IRE1α), and its downstream target,  the spliced form of 
XBP1 gene, phosphorylated eukaryotic initiation factor 2α (P-eIF2α), and activation of 




16-24h of ZIKV infection in trophoblasts. Inhibition of JNK or pan-caspases using small 
molecule inhibitors significantly prevented ZIKV-induced apoptosis in trophoblasts. 
Further, JNK inhibition also reduced XBP1 gene splicing and viral E protein staining in 
ZIKV infected cells. In conclusion, the mechanism of ZIKV-induced placental 
trophoblast apoptosis involves the activation of ER stress and JNK activation and the 
inhibition of JNK dramatically prevents ZIKV-induced trophoblast apoptosis. 
2.2 Introduction 
Zika virus (ZIKV) infection reports were sporadic in the African continent but 
later gained significance due to 2015 endemic outbreaks. ZIKV was first isolated from a 
febrile macaque in the Ugandan Zika forest and only few cases of human infections were 
reported in early 1940s. ZIKV infection during pregnancy is associated with congenital 
Zika virus syndrome (CZS) (1). Infected infants manifest severe birth defects such as 
microcephaly, retinal defects and intrauterine growth retardation (IUGR) leading to still 
births as well as increased infant mortality after 2 to 3 days postpartum (2).  
ZIKV is a single stranded positive sense RNA virus and its 10.8 kb genome can 
be directly translated into viral proteins. There are 3 structural proteins needed for 
assembly of viral particles such as envelope, precursor membrane protein and capsid 
protein, and 7 non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5), 
which aid in replication of the virus and are involved in attenuating host innate immune 
response (3-6). Virus size is roughly 50 nm with 180 copies of envelope and membrane 




the virus forms raft configuration with three protein dimers arranged in parallel manner 
(7). 
ZIKV infection is known to cause cell cycle arrest and apoptosis in progenitor 
neuronal cells, placental trophoblast and Hofbauer cells (8-11). Placental route plays a 
major role in disease transmission from the ZIKV infected mother to the fetus. The 
normal physiological role of the placenta, as a transient organ connecting the dam and the 
fetus is crucial for the fetal growth and survival through several functions like nutrient 
transport, respiratory gas exchange and metabolism of waste products (12). Stromal cores 
in the chorionic villi includes the fetal blood vessels and Hofbauer cells (placental 
resident macrophages) which regulate the branching of the villous (13). Recent studies 
suggest that placental epithelial cells and the other placental cells such as endothelial 
cells and Hofbauer cells can also be infected and results in dissemination of ZIKV from 
mother to fetus (14-16).. ZIKV was found to actively replicate in placental fibroblasts 
and Hofbauer cells resulting in spread of the infection to the neuronal progenitor cells of 
the fetal brain (17). Further, T cell immunoglobulin and mucin domain 1 (TIM1) 
(18)which are considered as important  cofactor for the entry of ZIKV into cells is highly 
expressed in cytotrophoblasts, invasive cytotrophoblasts, placental fibroblasts, umbilical 
vein endothelial cells, hofbauer cells and amniochorionic membranes(16,19). Other 
cofactors such as Tyro3 and Axl (18,20), implicated in ZIKV entry are also variably 
expressed in the placental cells (16). In the present study, we show evidence for ZIKV 





2.3 Materials and methods 
Cells: HTR-8/SVneo (HTR-8), normal human immortalized first-trimester placental 
trophoblast cells, and choriocarcinoma-derived third-trimester placental trophoblast cell 
lines (JEG-3 and JAR) were used. JAR and HTR-8 cells were cultured in DMEM 
containing 10% fetal bovine serum, 0.01% plasmocin. JEG-3 cells were cultured in MEM 
containing 10% fetal bovine serum, and plasmocin (0.01%). All the cells used the present 
study were obtained from ATCC and periodically tested for mycoplasma 
Antibodies: Primary antibodies against ZIKV E protein (# GTX133314) from Gene Tex, 
Inc. CA, eIF2α (# 5324), p-eIF2α (# 3388), p-p38 (# 9211),p38 (# 9212), p-JNK(# 9251), 
JNK (# 9252), IRE1α(# 3294), CHOP (# 2895), Bip (# 3183), HDAC1(# 34589), 
HERPUD1(# 26730), GADD45 (# 46325) and BCl2 (# 15071) were purchased from Cell 
Signaling Technologies, MA. Phospho-IRE1α antibody (# ab48187) was obtained from 
abcam and Actin antibody (# A-5441) was from MilliporeSigma, MA. Rabbit HRP-
conjugated secondary antibody (#111-035-144) and mouse HRP-conjugated secondary 
antibodies (# 715-035-150) were obtained from Jackson ImmunoResearch, PA. Alexa 
flour 488 conjugated anti-rabbit antibody (# A11008) and Alexa flour 594 conjugated 
anti-mouse antibody (# A-11032) were obtained from Invitrogen,CA.  
Viral Strains and trophoblast infection: MR766 strain (originally isolated from 
sentinel monkey in Uganda), recombinant MR strain (r-MRV) of Zika virus is generated 
as described (21), and PRVABC-59 strain (Asian lineage derived American strain from 
2015 outbreak in Puerto Rico) were used in the present study. Trophoblasts were infected 
with 0.1 -1 multiplicity of infection (MOI) in the infection media MEM (Gibco) 




20mM HEPES, 1 mM sodium pyruvate, and 1x nonessential amino acids and 0.01% 
plasmocin for 1 to 2h. After virus adsorption, the media was replaced with DMEM or 
MEM containing 10% fetal bovine serum and 1% BSA.  
Characterization of apoptosis: Biochemical and structural markers of apoptosis like 
caspase 3/7 activity and percent apoptotic nuclear morphological changes, respectively. 
Caspase 3/7 (effector caspase) activity was measured by enzymatic fluorophore release 
(Apo-One) according to the manufacturer’s instructions (Promega, Madison, WI 
#G7791) and reported as fold change compared to vehicle treatment or mock infection, 
with experiments performed in quadruplicate. Cells were seeded in 24 well plates, 
infected with ZIKV for 48 to 72h and percent apoptosis was quantified by characteristic 
nuclear morphology as described (22) and visualized by treatment with the fluorescent 
DNA-binding dye, DAPI (4’, 6-diamidine-2-phenylindole dihydrochloride) as described 
(22). Briefly, cells were stained with 5 μg/mL of fluorescent DNA-binding dye, 4’, 6-
diamidine-2-phenylindole dihydrochloride (DAPI) for 20 minutes at 37ºC. Apoptotic 
nuclei (condensed, fragmented) were counted and presented as a percent of total nuclei. 
At least 100 cells were counted per well and experiments were performed in triplicate.  
Quantitative real time Polymerase Chain Reaction: Cells were infected with ZIKV 
and the total RNA was isolated using TriZOL reagent (Thermo Scientific). Around 1-5 
µg RNA from each sample was reverse transcribed to cDNA with random hexamers, 
RNAse OUT and Superscript II reverse transcriptase with low RNAse H activity 
(Invitrogen). CHOP mRNA and 18S rRNA were quantified using primers listed in table 





Table 2.1 Primer details 
Primer Forward primer Reverse primer Product length 
XBP1 5’AAACAGAGTAGCAG
























CAG TGTAG 3’ 
~212bp 
 
XBP1 splicing assay:  Approximately 5µg total RNA diluted 1:3 (JEG-3 and JAR cells) 
or 1:10 (HTR-8) was used for cDNA synthesis. Then it was subjected to PCR to amplify 
XBP1 gene using the primer set (each 20µM)  as described (24). Around 8 µL of the 
obtained PCR product was digested with 20 U of PstI (New England Bio labs) in 
1µLNEB buffer containing 100 mM NaCl, 50 mM Tris-HCl,10 mM MgCl2 and 100 
µg/mL BSA and incubation was done at 37oC for 2h. The restriction enzyme digested 
PCR product was electrophoresed in 2% agarose gel stained with ethidium bromide. The 
unspliced forms are around 474 bp and the restriction endonuclease digested products 




visualized around 448bp. GAPDH was used as control and was amplified by the primers 
listed in table 2.1.  
Western blot analysis: Cell lysates were prepared by adding 100µL of lysis buffer 
containing 50mM Tris pH 7.4, 150mM NaCl, 1mM EDTA, 1mM DTT, 1mM Na3Vo4, 
1mM PMSF, 100mM NaF and 1% Triton x-100. Cells were scraped, incubated for 40 
minutes in ice and cell supernatant was prepared after 10,000 x g for 10 min of 
centrifugation. Protein estimation was done using modified Lowry method using Pierce 
660nm protein assay reagent (ThermoFisher Scientific). Around 30µg protein was 
separated in a 10% polyacrylamide gel or 4 to 20% gradient gel and then transferred into 
nitrocellulose membrane. The membrane was blocked with either 5% skim milk powder 
in TBST or with 5% BSA in TBST. Primary antibody was used in 1: 1000 dilution in 5% 
skim milk powder in TBST or with 5% BSA in TBST. Secondary antibody was used in 
1:500 dilution.  Washes of 10 mins for 3 times were given after both primary and 
secondary antibody incubation.  The blots were developed using Clarity Western ECL 
substrate or Clarity Max ECL substrate (Bio-Rad).  
Isolation of nuclear proteins: Cells were scraped in buffer containing 10mM HEPES, 
10mM KCl, 0.1mM EDTA, 0.1 mM DTT, 0.5% nonidet-P40 substitute (Sigma) and 
protease inhibitor and cell lysate were incubated for 10min in ice. Cell lysates were 
centrifuged at 15,000 x g for 3 mins. The supernatant has cytoplasmic proteins and to the 
settled precipitated nuclear contents 50-100 µL of buffer B containing 20mM HEPES, 
0.4M NaCl, 1mM EDTA, 0.05mM DTT, 10% glycerol and proteinase inhibitor was 
added and incubated in ice with intermittent vortexing for 40 mins and then centrifuged at 




Immunofluorescence analysis: Placental trophoblast was infected with ZIKV, 0.1 MOI 
for 48-72h. Infected cell media was aspirated and fixed with methanol and acetone (ratio 
of 1:1) and washed with PBS. Blocking was done using solution containing 1% BSA and 
22.52 mg/mL glycine in PBST. Zika virus envelope protein (E protein) rabbit polyclonal 
was used at a dilution of 1:500 or CHOP mouse monoclonal antibody at a dilution of 
1:400 was used and incubated overnight at 4oC. After primary antibody incubation, cells 
were washed thrice with PBS with an interval of 5 mins each. Alexa flour 488/594 
conjugated secondary antibody was added at a dilution of 1:1000 and kept in a shaker at 
room temperature for 2h. After incubation, the cells were washed thrice in PBS, counter 
stained with DAPI (0.3 µM) for 10mins at 37oC and washed with PBS.  Images were 
taken using EVOS FL microscope (Thermo Fisher) or Nikon A1R-Ti2 confocal system. 
Statistical analysis: Analysis of variance (ANOVA) with post-hoc Bonferroni 
corrections was employed for comparisons of multiple groups and Student’s t-test were 
performed for comparisons between two groups. P value <0.05 was considered 
statistically significant.  
2.4 Results 
Zika Virus infection induces placental trophoblast apoptosis: We performed 
immunofluorescence analysis in placental trophoblasts (HTR-8 cells) infected with 0.1 
MOI of r-MRV or PRV strain of ZIKV. We observed viral E protein staining after 72h in 
ZIKV infected trophoblasts, while there was no staining observed in vehicle or mock 
infected trophoblast cells (Fig. 2.1A). We also analyzed the expression of viral E protein 




dramatically increased at 16 or 24h post infection of ZIKV in JEG-3, JAR and HTR-8 
cells compared to mock infected cells. The levels of beta-actin were used as control and 
remains unchanged at different timepoints of infected cells and mock infected 
trophoblasts (Fig 2.1B).    
Next, we assessed biochemical characteristics of apoptosis such as caspase 3 and 7 
activation and nuclear morphological changes with ZIKV infection in placental 
trophoblast cells. Both first trimester-derived trophoblast (HTR-8) and term-derived 
trophoblast cells (JEG-3) cells infected with 1.0 MOI of MRV (MR766) and PRV strains 
of ZIKV, 48h post infection showed a significant increase caspase 3 and 7 activity and 
percent apoptotic nuclei  indicating apoptosis (Fig. 2.2A). We also assessed trophoblast 
apoptosis with 0.1 MOI of r-MRV strain after 48-72 hours of infection  and, we observed 
a significant increase in caspase 3/7 activity and percent apoptotic nuclei in placental 
trophoblasts (JEG-3, JAR and HTR-8) (Fig. 2.2B-D). We also observed a trend in 
downregulation of anti-apoptotic Bcl2 protein with 0.1 MOI of r-MRV strain of ZIKV 16-
24 h post infection in JEG-3 and HTR-8 cells (Fig S1). These data suggest that ZIKV 












Fig.2.1. ZIKV infects placental trophoblasts. 
(A) Immunofluorescence staining of Viral E protein in HTR-8 (HTR-8/SVneo) cells 72h 
post infection with 0.1 multiplicity of infection (MOI) recombinant MR strain (r-MRV) 
or PRVABC-59 (PRV) or uninfected vehicle cells. Nuclei were stained with DAPI and 
ZIKV E protein stained with rabbit polyclonal primary antibody and Alexaflour 488-
conjugated ant-rabbit secondary antibody. (B) Western blot analysis showing increased 
expression of viral E protein, 16-24h post infection when compared to uninfected vehicle 




Supplementary Fig.1. ZIKV infection results in downregulation of anti-apoptotic Bcl2. 
Representative western blot showing anti-apoptotic Bcl2 is downregulated in JEG3 and 












Fig. 2.2. ZIKV infection induces placental trophoblast apoptosis.  
(A) JEG-3 and HTR-8 infected with 1.0 MOI MRV or PRV showing significant increase 
in caspase 3/7 activity when compared to uninfected vehicle cells (left panel). Similarly, 
ZIKV infection with 1.0 MOI MRV or PRV also showed increased percentage apoptotic 
nuclei compared to uninfected vehicle cells (right panel). Similarly, ZIKV infection with 
0.1 MOI r-MRV to placental trophoblast also induces apoptosis as evidenced by an 
increase in caspase 3/7 activity and percent apoptotic nuclei and in JEG-3 (B), JAR (C) 
and HTR-8 (D) cells compared to uninfected vehicle cells. Each value presents mean ± 
SEM of biological replicates (n=4) for caspase 3/7 activity and (n=3) for percentage 
apoptotic nuclear morphology, *P<0.05 compared to uninfected vehicle cells; statistical 
comparison by Student’s t-test. 
 
ZIKV infection in trophoblasts induces CHOP nuclear translocation, a 
transcription factor that can activate apoptosis: Sustained ER stress can progress the 
cells into apoptosis either via CHOP or JNK activation (25). Active and spliced XBP1 
can trancriptionally increase expression of ER stress response proteins like CHOP (26). 
We examined whether ZIKV infection can induce the expression of other downstream 
targets that activates apoptosis. We tested the nuclear translocation of CHOP with 0.1 
MOI r-MRV ZIKV infection in trophoblasts and confirmed that there was increased 
nuclear translocation of CHOP protein after 24h ZIKV infection in JEG and JAR cells 
(Fig. 2.4A). Similarly, there was a trend in increase in the levels of CHOP mRNA, 24h 
post infection in both JAR and JEG-3 cells where as it was 8h post infection in HTR-8 
cells (Fig. S2). We also observed a significant increase in CHOP mRNA expression 48h 
post infection compared to uninfected vehicle cells in both JEG-3 and JAR cells (Fig. 
2.4B). We further confirmed CHOP nuclear translocation in JEG-3 (Fig. 2.4C) and JAR 
cells (Fig 2.4D) using immunofluorescence analysis. We observed enhanced CHOP 
nuclear localization surrounded by viral E protein staining in the cytoplasm of r-MRV 




Growth Arrest and DNA Damage-inducible 45 (GADD45) which can activate and 
promote apoptosis. Interestingly, we found that the nuclear levels of GADD45 were 
increased after 24h of ZIKV infection in JAR cells and JEG-3 cells (Fig. 2.3A). Further, 
JEG-3 cells infected with PRV 24-48 h post infection showed increased nuclear 
translocation of CHOP (Fig 2.3A, bottom panel). However nuclear levels of GADD45 
were increased only after 48 h of infection with PRV, when compared to uninfected 
vehicle cells (Fig 2.3A, bottom panel). These data suggests that both MRV and PRV 










 Fig. 2.3. ZIKV infection induces the expression CHOP, a transcription factor that 
activate apoptosis.  
(A) Immunoblot analysis showed an increase in the expression of CHOP in nuclear 
extracts of ZIKV infected cells (0.1 MOI r-MRV) compared to vehicle uninfected cells in 
JEG-3  (left panel) and JAR cells (right panel), increased nuclear levels of CHOP can act 
as an initiator for apoptosis. JEG-3 (left panel) and JAR cells (right panel). We also 
observed increased GADD45 levels in nuclear protein, which is produced in response to 
DNA damage, after 24h of infection in JAR cells (right panel) with 0.1 MOI of r-MRV 
compared to uninfected vehicle cells and this increase of GADD45 in the infected cells 
was absent in JEG-3 (left panel). HDAC1 was used as a loading control. We also 
observed increase in expression of CHOP nuclear protein both 24 and 48h post infection 
and GADD45 nuclear protein around 48h post infection in JEG-3 cells with 0.1 MOI 
PRV (lower middle panel). (B) JEG-3 (left panel)  and JAR (right panel) cells after 48h 
of 0.1 MOI of r-MRV showed significant increase in CHOP mRNA levels compared to 
uninfected vehicle cells. CHOP mRNA expression were reported relative to 18S rRNA. 
Each value presents mean ± SEM of biological replicates (n=3), *P< 0.05 compared to 
uninfected vehicle cells; statistical comparison by Student’s t-test. (C) 
Immunofluorescence analysis was also performed to test CHOP nuclear translocation by 
using Viral E protein staining indicated as green signal and CHOP as red signal. (C) JEG-
3 cells: uninfected vehicle cells showed no viral E protein staining but has endogenous 
CHOP expression. Cells infected with 0.1MOI r-MRV show nuclear CHOP expression 
surrounded by viral E protein staining in the cytoplasm in the merged panel. (D) JAR 
cells: uninfected vehicle cells show no viral E protein staining but endogenous CHOP 
expression is seen. Cells infected with 0.1MOI r-MRV showed increased nuclear CHOP 
expression surrounded by viral E protein staining in the cytoplasm showed in the merged 





Supplementary Fig.2. CHOP expression in ZIKV infected placental trophoblasts. 
CHOP mRNA expression is showing a trend towards increase around 24h post infection 
with 0.1 r-ZIKV MR strain in JEG-3 (A), (B) JAR and (C) HTR-8 compared to 
uninfected or mock-infected vehicle cells. 
ZIKV infection induces ER stress in placental trophoblasts: We examined the 
activation of IRE1α arm of ER stress with ZIKV infection in placental trophoblasts. We 




24h of ZIKV infection, suggesting that the ER stress sensor proteins are activated in JEG-
3, JAR and HTR-8 (Fig 2.4 A-C). However, the levels of total IRE1α protein were 
unchanged (Fig. 2.4 A-C). Activated IRE1α, an endoribonuclease is known to enhance 
the splicing and processing of XBP1 mRNA. We next examined the downstream target of 
activated IRE1α that is enhanced splicing of XBP1 gene.  We observed a dramatic 
increase in the levels of XBP1 gene splicing 8- 24h post infection in JEG-3, JAR and 
HTR-8 cells (Fig. 2.4D-E). JEG-3 and JAR cells showed a time dependent increase in the 
active spliced form of XBP1 which was dramatically increased in 24h. In HTR-8 cells, 
there was active form of spliced XBP1 particularly evident at 8h post infection. GAPDH 
was used as loading control. ER stress has been shown to block global protein translation 
(27). Host immune defense such as antiviral response by interferons are also known to 
activate eIF2α via phosphorylation (28). We assessed the activation of eIF2α via 
phosphorylation. ZIKV infection of placental trophoblast showed increased levels of 
phosphorylated eIF2α (P-eIF2α) after 24 hours of infection in JEG-3 and HTR-8 cells 
whereas activation of eIF2α was observed after 16h of infection in JAR cells and the 
levels of total eIF2α remain unaltered (Fig.2.5A). Increased P-eIF2α levels can block 
global protein translation in the placental trophoblasts with ZIKV infection. We also 
found that Bip/GRP78, regulator of ER stress is slightly increased 24h post infection in 
JEG cells but this increase did not correspond to JAR and HTR-8 cells with ZIKV 
infection (Fig.2.5B). Homocysteine Inducible ER Protein with ubiquitin like domain 1 
(HERPUD1) expression also remained unchanged in both vehicle and r-MRV infected 












Fig.2.4. ZIKV infection activates IRE1α arm of ER stress in placental trophoblasts.  
(A) Western blot images shows increased levels of phosphorylated IRE1α after 24 hrs of 




was observed in JAR cells after 24h of infection and HTR-8 cells also showed increased 
phospho- IRE1α after 16-24h of ZIKV infection compared to uninfected vehicle cells.  
Trophoblasts were infected with 0.1 MOI r-MR and XBP1 splicing was observed after 8, 
16 and 24 hrs of infection. (C) JEG 3 cells showed an increased spliced form of XBP1 
mRNA at 24h post infection. (D) JAR cells infected with 0.1 MOI r-MR strain showed 
increased levels of spliced XBP1 at 24h post infection compared to mock-infected or 
uninfected vehicle cells. (E) HTR-8 cells infected with 0.1 MOI, r-MR showed increased 
XBP1 spliced form starting from 8 h post infection and stayed until 24 hr post infection. 
The unspliced XBP1 cDNA is cleaved by PstI restriction enzyme and shows faster 
migration pattern than the spliced form. GAPDH was amplified as a loading control. 
 
Fig.2.5. ZIKV infection and ER stress markers in trophoblasts.  
(A) Western blot showing increase in the expression of phosphorylated eIF2α after 24h of 
infection with 0.1 MOI r-MRV in both JEG-3 and HTR-8 (HTR-8 SV/neo) cells and 16h 
post infection in JAR cells compared to uninfected vehicle cells. Total eIF2α levels 
remained constant. (B) ZIKV infected trophoblast also showed an increase in the levels 
of Bip/GRP78 in JEG-3 but not in JAR and HTR-8 cells compared to uninfected vehicle 
cells. (C) HERPUD1 levels were unchanged in uninfected and ZIKV infected JEG-3, 




Activation of Mitogen Activated Protein Kinase (MAPK): ER stress-induced 
activation of IRE1α has been shown to activate JNK (29,30). To assess the mechanism of 
ZIKV-induced placental trophoblasts, we sought to test the activation of JNK, which can 
initiate apoptotic cell death during sustained ER stress. ZIKV infection in JEG-3 cells 
showed increased levels of JNK phosphorylation after 16-24 h of infection suggesting an 
activation of JNK (Fig.2.6A). Similarly, we also observed an increase in phospho-JNK 
levels in JAR and HTR-8 cells, 24 h post infection in comparison to the total JNK levels 
(Fig.2.6 B, C).  We also tested 0.1 MOI of PR strain infection in JEG-3 cells and 
observed increased phosphorylation of JNK, 24h and 48h post  infection (Fig.2.6D) when 
compared to uninfected vehicle cells. These data provide insights on the mechanism of 
ER stress and its contribution to the apoptotic signal. p38 MAPK is known have a 
regulatory control on CHOP (31), also p38 activation in DENV is known to be associated 
with hepatic damage(32). Here we found that ZIKV infection also activates p38 MAPK 
via phosphorylation in JEG-3, HTR-8 cells after 24h of infection (Fig.2.6A, C) and in 
JAR cells it was more prominently after 16h of infection (Fig.2.6B). These data suggest 










Fig.2.6. Activation of Mitogen Activated Protein Kinase (MAPK) in ZIKV infected 
trophoblasts.  
(A) Immunoblot analysis of JNK and p38 activation via phosphorylation were observed 
8-24h after infection with 0.1 MOI r-MRV in JEG-3 cells showed increase in 
phosphorylation of p54 and p46 components of JNK and phosphorylation of p38 MAPK 
as well compared to uninfected vehicle cells. Similarly, JNK and p38 activation via 
phosphorylation was also observed in JAR cells (B) and HTR-8 (C) 24 h post infection 
with 0.1 MOI r-MRV compared to uninfected vehicle cells. Total JNK and Total p38 
levels were mostly unaltered between ZIKV infected and vehicle uninfected cells. (D) 
Activation of JNK was also seen with 0.1 MOI PRV 24h-48h post infection in JEG-3 
cells compared to uninfected vehicle cells. 
Inhibition of JNK prevents ZIKV-induced trophoblast apoptosis: We used small 
molecule inhibitors of ER stress mediators like selective dephosphorylation inhibitor of 
eIF2α (Salubrinal, 20µM), IRE1α inhibitor (STF-083010, 20 µM), JNK inhibitor 
(SP600125, 50 µM), p38MAPK inhibitor (SB203580, 50 µM) or pan caspase inhibitor 
(Z-VAD-FMK, 50 µM) to test the critical mediators of apoptosis. Similar to figure 2.1, 
ZIKV infection to trophoblast showed increased apoptosis as evidenced by dramatic 
increase in caspase 3/7 activity and percent apoptotic nuclei (Fig.2.7). Treatment of 
ZIKV-infected trophoblast with SP600125 and Z-VAD-fmk showed a significant 
decrease in caspase 3/7 activation and percent apoptotic nuclei in trophoblasts infected 
with ZIKV. These results suggest that JNK and caspase activation are critical pathway 




E). IRE1α inhibition using STF-083010 in JEG-3 cells showed partial protection against 
ZIKV-induced trophoblast apoptosis, however IRE1α inhibition does not significantly 
protect against ZIKV-induced apoptosis in HTR-8 cells (Fig.2.7). In contrast, inhibition 
of ER stress using salubrinal significantly protected against ZIKV-induced apoptosis in 
HTR-8 cells. Treatment of salubrinal in JEG-3 cells showed a slight non-significant trend 
in protection against ZIKV-induced apoptosis (Fig.2.7A). In JAR cells, caspase 3/7 
activity was significantly inhibited when the infected cells were treated with salubrinal, 
or SP600125 or Z-VAD-fmk. In contrast, treatment of p38 MAPK inhibitor, SB203580 
in ZIKV infected JAR cells showed significantly increased caspase 3/7 activation 
(Fig.2.7E). These data suggest that activation of caspases and JNK are critical in ZIKV-
induced trophoblast apoptosis. Similarly, XBP1 gene splicing assay showed increased 
XBP1 gene splicing in JEG-3 with 0.1MOI r-MRV after 48h post infection compared to 
uninfected vehicle cells (Fig.2.8A). On the other hand, when the MRV infected cells 
treated with SP600125 (JNK inhibitor), we observed a dramatic reduction in the levels of 
XBP1 splicing. Interestingly, treatment of Z-VAD-fmk to the ZIKV infected cells 
showed dramatic increase in XBP1 splicing and however treatment of salubrinal showed 
a moderate increase in XBP1 splicing compared to the 0.1rMRV infection alone 
(Fig2.8A).  We then analyzed the expression of viral E protein using 
immunofluorescence in JEG-3 cells with ZIKV infection. There was a dramatic increase 
in viral E protein staining in 0.1r-MRV infected JEG-3 cells but was absent in uninfected 
vehicle cells. The DAPI panel shows fragmented nuclei in the 0.1 rMRV infected cells. 
ZIKV Infected cells treated with SP600125 (JNK inhibitor) showed dramatic reduction in 




in the viral E protein staining compared to the infected cells. Interestingly, treatment of 
Z-VAD-fmk in 01.rMRV infected cells showed enhanced viral E protein staining and the 
nuclei in the DAPI panel are intact confirming the fact that Z-VAD-fmk has inhibited 
apoptosis suggesting that the viral particles are trapped inside the cells with the inhibition 
of caspase activity and are protected from viral release for further infection. These data 
suggests that ZIKV induces ER stress in a JNK-dependent manner and inhibition of JNK 








Fig.2.7. Inhibition of JNK prevents ZIKV-induced trophoblast apoptosis.  
(A-B) JEG-3 cells infected with 0.1 MOI of r-MRV for 48 h showed significant increase 
in apoptosis as evidenced by caspase 3/7 activity and percent apoptotic nuclear compared 
to uninfected vehicle treatment. ZIKV-induced placental trophoblast apoptosis were 
significantly prevented in JEG-3 cells infected with 0.1 MOI of r-MRV and IREi (STF-
083010, IRE1α inhibitor), JNKi (SP600125, JNK inhibitor), or ZVAD (Z-VAD-fmk, pan 
caspase inhibitor) treatment, respectively. However, ZIKV infection and treatment of Sal 
(Salubrinal, eIF2α dephosphorylation inhibitor) did not prevent trophoblast apoptosis. (C-
D) HTR-8 cells infected with 0.1 MOI of r MRV for 72 h showed a dramatic increase in 
biochemical markers of apoptosis compared to uninfected vehicle cells.  ZIKV-induced 
placental trophoblast apoptosis were significantly prevented in HTR-8 cells infected with 
0.1 MOI of r-MRV and Sal (Salubrinal, eIF2α dephosphorylation inhibitor), JNKi 
(SP600125, JNK inhibitor), or ZVAD (Z-VAD-fmk, pan caspase inhibitor) treatment, 
respectively. However, ZIKV infection and IRE inhibition (STF-083010, IRE1α 
inhibitor) or p38 inhibition treatment does not prevent ZIKV-induced trophoblast 




activation of caspase 3/7 when compared to vehicle cells. Sal (Salubrinal, eIF2α 
dephosphorylation inhibitor), JNKi (SP600125, JNK inhibitor), or ZVAD (Z-VAD-fmk, 
pan caspase inhibitor) treatment in infected cells inhibited caspase 3/7 activation while 
p38 inhibition significantly increased caspase 3/7 activation. Each value represents mean 
± SEM of n=4 for caspase 3/7 activity and n=3 for percent apoptotic nuclei, *P < 0.05 
compared to uninfected vehicle cells; #P<0.05 compared to ZIKV infected cells; 









Fig.2.8. Inhibition of JNK reduces XBP1 gene splicing and viral E protein.  
(A) JEG-3 cells showed an increase in the splicing of XBP1 gene of the IRE1α arm of ER 
stress pathway with 0.1 MOI r-MRV, 48h post infection compared to uninfected vehicle 
cells. XBP1 gene splicing was reduced in the infected cells cotreated with JNKi 
(SP600125, JNK inhibitor).  XBP1 gene splicing were increased in infected cells 
cotreated with ZVAD (Z-VAD-fmk, pan caspase inhibitor), similarly a moderate increase 
in XBP1 gene splicing were observed in Sal (Salubrinal, eIF2α dephosphorylation 
inhibitor) cotreatment to infected cells. (B) JEG-3 cells with 0.1 MOI r-MRV infection 
also showed viral E protein staining and fragmented nuclei in the DAPI staining 
compared to the uninfected vehicle cells. Treatment of JNKi (SP600125, JNK inhibitor) 
to r-MRV infected cells showed reduced E protein staining whereas the ZVAD (Z-VAD-
fmk, pan caspase inhibitor) treated infected cells showed huge increase in viral E-protein 




dephosphorylation inhibitor) treated infected cells also showed moderate viral E protein 
staining compared to r-MRV infected cells.  
2.5 Discussion  
The mechanism of ZIKV infection-induced trophoblast apoptosis is via activation of ER 
stress markers and JNK activation. The principal findings of this manuscript are: 1) ZIKV 
infection induces caspase dependent apoptosis; 2) ZIKV infection induces three arms of 
ER stress; 3) Nuclear translocation of CHOP was observed in trophoblasts infected with 
ZIKV; and 4) Activation of JNK plays a critical role in ZIKV infection-induced 
trophoblast apoptosis. Even though initially it was thought that term placenta is resistant 
to ZIKV infection (33) later it was found that ZIKV can cross the placental barrier by 
compromising the tight junctions (34). Human placenta explant studies have also showed 
that there was an effective ZIKV replication in the placental tissues and trophoblast 
apoptosis (35).  There are also reports showing ZIKV replication in placental trophoblast 
cell lines (20,36,37).ZIKV is known to activate innate immune pathways leading to 
inflammation in placental trophoblasts(20,37).  ZIKV infection can also cause placental 
trophoblasts to undergo apoptosis and release of new viral particles from the dead cells 
could facilitate ZIKV infection and spread to the growing fetus (38). Interestingly, innate 
immune pathways can also stimulate apoptosis(39). We also have observed caspase 
activation and characteristic apoptotic nuclear morphological changes in ZIKV infected 
trophoblasts, both first and third trimester-derived trophoblasts cells.  ZIKV infected 
human fetal neural parenchymal tissue showed increased expression of Fas and Fas 
ligand suggesting that apoptosis contributes to fetal brain injury in ZIKV-induced 
microcephaly (40,41). Our data suggest that there was slight decrease in anti-apoptotic 




stages of infection to ensure the effective production of virions by regulating Bcl2 (42), 
this could be attributed to the reason that we could see only subtle changes in the  Bcl2  
levels after 8h to 24h of infection, a time point where we observed changes in ER stress 
markers. These data suggest that ER stress precedes apoptotic events with ZIKV 
infection in trophoblasts. Further time course studies are required to measure the levels of 
pro-apoptotic and anti-apoptotic proteins with ZIKV infection-induced trophoblast 
apoptosis.  
Flaviviruses are closely associated with ER stress as they replicate within the 
cellular membrane bound organelles, especially ER. Accumulation of structural and non-
structural proteins in the ER results in the formation of convoluted spherules, which 
activates unfolded protein response (UPR). Apart from this, they also remodel ER in 
terms of its protein and lipid content (43,44). Zika virus is a positive stranded RNA virus 
that has been shown to replicate in the ER membrane (44). During viral infection, host 
cells activates UPR to combat the viral protein load in the ER membranes and induces 
ER stress and prolonged ER stress result in apoptosis (45,46). Further, ZIKV infection to 
neural progenitor cells were also shown to upregulate ER stress and apoptosis and could 
results in the pathophysiology of ZIKV-associated microcephaly (47,48). ER stress 
activates three different arms of the UPR, namely the PERK pathway, the IRE1α pathway 
and the ATF6 pathway. There is always crosstalk among these pathways that orchestrates 
signals leading to survival or death of cells (49).   
Sustained ER stress and splicing of XBP1 gene corresponds well to apoptosis 
(50,51).  IRE1α and XBP1 targets were also shown to be activated in ZIKV infected 




normal protein folding in the ER and biosynthesis of ER (53). We observed increased 
apoptosis in placental trophoblasts with ZIKV infection along with increased XBP1 
splicing and IRE1α activation suggests that the mechanism of ZIKV-induced apoptosis 
could be due to the sustained ER stress (50,51).  
Sustained ER stress-induced IRE1 α activation has also been shown to activate 
MAP Kinases like JNK and p38 MAPK via phosphorylation. Sustained or prolonged ER 
stress is known to activate IRE1α which can result in the IRE1α dependent activation of 
JNK and p38 MAPK in association of Apoptosis signal-regulating kinase 1 (ASK1) and 
TNF Receptor Associated Factor 2 (TRAF2) can results in apoptosis (54,55). Further, 
p38 MAPK is a critical regulator of pro-inflammatory cytokine and is found to be 
involved in ZIKV induced inflammation of neuronal cells of the retina (56). Further 
studies are underway to elucidate the critical role for p38 MAPK activation in 
inflammatory processes in placental trophoblasts with ZIKV infection.  
Global protein translation shutdown was observed in ZIKV infected trophoblast 
as evidenced by enhanced phosphorylation of eIF2α suggesting PERK activation (57). 
Double-stranded RNA-dependent protein kinase (PKR) also phosphorylates eIF2α which 
is associated with antiviral interferon signaling pathway to keep viral replication under 
control (58). Despite the potential to encounter a strong anti-viral interferon response, 
ZIKV evades the innate immune system by modulating RIG-I (retinoic acid-inducible 
gene I) like receptor (RLR) signaling, thereby diminishing the effect of anti-viral 
interferon response to the replicating ZIKV (59). Increased levels of phospho-eIF2α is 
known to increase the formation of stress granules which composes preinitiation 




mechanism and uses the stress granule components to their advantage to aid their own 
replication (60,61). Bip or GRP78 is a chaperone that binds to the ER membrane proteins 
IRE1α, PERK and ATF6 in normal resting state, under ER stress it gets dissociated 
allowing the membrane proteins to be activated (62). PERK phosphorylation leads to 
ATF4 transcription which in turn results in CHOP nuclear activation (63,64). CHOP 
primes the cell for apoptosis by decreasing the expression of anti-apoptotic Bcl2 proteins 
and increasing expression of GADD45 (65,66). Our data suggests that ZIKV infection 
induces both CHOP and GADD45 levels in the nucleus. Further, GADD45 is known to 
be associated with regulation of apoptosis under stress or DNA damage (67). Bip, a 
master regulator of ER stress is slightly increased 24h post infection in JEG cells but this 
increase did not occur in JAR and HTR-8 cells with ZIKV infection. In a study involving 
Borna disease virus, Purkinje cells showed CHOP induction without upregulation in the 
Bip levels. However, astrocytes showed the nuclear activation of CHOP along with Bip 
upregulation, it was suggested that upregulation of proteins like Bip and protein-disulfide 
isomerase can protect the cells from apoptosis or delay apoptosis and different cell types 
responds to ER stress in different ways (68). HERPUD1, an ER resident protein and a 
component of ERAD pathway has been shown to be upregulated in Enterovirus 71 
infections. HERPUD1 upregulation is associated with limiting virus replication by 
generating interferon mediated immune response (69). It is unclear whether HERPUD1 
upregulation is prevented during ZIKV infection in trophoblasts to ensure a productive 
infection by avoiding any innate immune response. However, further studies are required 




JNK is a master regulator of various physiological processes and are activated in 
response to stress and can modulate cell survival and cell death pathways (70). Our data 
show that inhibition of JNK using small molecule led to the discovery that ZIKV-induced 
trophoblast apoptosis is a JNK-dependent process.  JNK activation was also recently 
reported in mouse brain with ZIKV infection and in dengue virus infected human 
macrophages (71,72). In our study we found that JNK activation is critical in activating 
caspases to cause programmed cell death in ZIKV infected placental trophoblasts. JNK 
activation is also well-established mediator that drives the cells undergoing ER stress into 
apoptotic pathway. Activation of JNK is known to enhance the translocation of Bax and 
Bak to the mitochondria, leading to Bax-Bak oligomerization and mitochondrial pore 
formation, which can result in activation of intrinsic pathway of apoptosis (73,74). 
ZIKV-induced trophoblast apoptosis was also protective with different inhibitors 
of ER stress pathway in a cell specific manner.  Inhibition of IRE1α protects against 
apoptosis in third trimester derived placental trophoblasts. Selective inhibition of eIF2a 
dephosphorylation using salubrinal protects ZIKV infection-induced first trimester-
derived trophoblast apoptosis. However, further studies are required to elucidate the 
protective role of ER stress inhibitors in suitable animal models of infection at various 
gestational ages. Expression profile of ZIKV viral entry cofactors varies in the placenta at 
different stages of gestation, for example, TIM1 is highly expressed in both JEG-3 and 
HTR-8/SVneo cells but Axl is not expressed in JEG-3 cells (16). Viral entry is a crucial 
step for replication and there might be a time lag in the replication cycle based on the 
presence or absence of different viral entry cofactor expression and this could in turn alter 




extravillous portion of the first trimester trophoblasts, recent studies show that they 
contain a population of trophoblasts as well as mesenchymal cells (75) and further HTR-
8/SVneo cells undergo epithelial mesenchymal transition which is a characteristic feature 
in placental development throughout the gestation period (76).  Further we also show 
reduction in XBP1 gene splicing and viral load with JNK inhibition in ZIKV infected 
cells linking JNK activation and ER stress pathways. Treatment of salubrinal to ZIKV 
infected cells caused moderate decrease in XBP1 gene splicing and viral load, 
respectively. Interestingly, inhibition of pan-caspase activity caused extensive XBP1 gene 
splicing in the infected cells and increased viral load as the viral E proteins are trapped 
inside the cells and are unable to be released due to inhibition of apoptosis as previous 
reported (77).  A study found that inhibition of autophagy can limit ZIKV infection, this 
could be correlated to the fact that JNK also has a regulatory control on autophagy 
pathway and studies have shown that JNK inhibition also causes inhibit autophagy (78-
80).  
2.6 Conclusion 
In conclusion, our data suggest that ZIKV infection induces ER stress and 
placental trophoblast apoptosis. Mechanistically, we have identified that JNK is a critical 
mediator of ZIKV-induced trophoblast apoptosis. Further studies are required to identify 
the molecular mechanism of JNK activation and other interacting partners with ZIKV 
replication. Trophoblasts are the major cell type that interacts with maternal decidua and 
maternal blood circulation. Protective strategies against ZIKV infection in trophoblast 
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CHAPTER 3: PALMITOLEATE PROTECTS AGAINST ZIKA VIRUS-
INDUCED PLACENTAL TROPHOBLAST APOPTOSIS 
 Muthuraj et al., Biomedicines, 2021 May; 9(6):643 
(PMID: 33500388) 
3.1 Abstract 
Zika virus (ZIKV) infection in pregnant women is associated with the development of 
microcephaly, intrauterine growth restriction, and ocular damage in the fetus. ZIKV 
infection of the placenta plays a crucial role in the vertical transmission from the maternal 
circulation to the fetus. Our previous studies suggested that ZIKV induces endoplasmic 
reticulum (ER) stress and apoptosis of placental trophoblasts. Here, we showed that 
palmitoleate, an omega-7 monounsaturated fatty acid, prevents ZIKV-induced ER stress 
and apoptosis in placental trophoblasts. Human trophoblast cell lines (JEG-3 and JAR) 
and normal immortalized trophoblasts (HTR-8) were used. We observed that ZIKV 
infection of the trophoblasts resulted in apoptosis and treatment of the infected cells with 
palmitoleate significantly prevented apoptosis. However, palmitate (saturated fatty acid) 
did not offer protection from ZIKV-induced ER stress and apoptosis. We also observed 
that the Zika viral RNA copies were decreased, and the cell viability improved in ZIKV-
infected cells treated with palmitoleate as compared to the infected cells without 
palmitoleate treatment. Further, palmitoleate was shown to protect against ZIKV-induced 
upregulation of ER stress markers, C/EBP homologous protein and X-box binding 








Zika virus (ZIKV) was originally identified in the Zika forest of Uganda from the blood 
sample of febrile macaque (1). ZIKV infection of humans was first reported to occur 
sporadically in the African continent in early 1960’s, but later ZIKV infection spread 
throughout the world including Yap islands, Pacific islands and the American continent 
between 2007 and 2016 (2). ZIKV is an arbovirus belongs to the Flaviviridae family and 
is closely related to dengue, chikungunya, and Yellow fever viruses (3). ZIKV usually 
causes self-limiting disease in a healthy individual, but infection during pregnancy often 
causes devastating effects to the fetus. ZIKV infected fetus exhibits Congenital Zika 
syndrome, which is an array of disease manifestations that includes microcephaly, retinal 
defects, and muscular-skeletal defects (4). Further, ZIKV infection is also associated with 
the development Guillain-Barre syndrome in adults (5). 
Placental route plays a major role in ZIKV transmission from the infected mother to the 
fetus. Studies suggest that placental trophoblasts, endothelial cells and Hofbauer cells can 
be infected and plays a crucial role in ZIKV dissemination from mother to fetus (6-9). 
ZIKV is also known to cause placental dysfunction by driving an inflammatory condition 
accompanied by apoptosis (8,10,11). Further, ZIKV infection of the placental cells was 
shown to compromise the normal physiological role of the placenta, which is crucial for 
the fetal growth and survival (12-14). ZIKV can also cause drastic changes in the 




There are several candidate ZIKV vaccine which include DNA vaccines, mRNA vaccine 
and whole live-attenuated virus or inactivated virus vaccines (16-19). Although several 
candidate vaccines progressed to early clinical trials, they are posed with serious 
challenges such as case detection after vaccination and vaccination strategies primarily 
focusing on females who are already pregnant or expecting pregnancy. Similarly, several 
drug candidates such as niclosamide (anti-parasite drug) and emircasin (pan-caspase 
inhibitor) to prevent ZIKV infection have been identified (20). However, the safety and 
administration of niclosamide during pregnancy is under debate (a pregnancy category B 
drug) and emricasin efficacy is solely attributed to its neuroprotective property rather 
than its anti-viral activity and has not been tested in pregnant women (21).  Similarly, 
sofosbuvir, a FDA approved nucleotide analog and an inhibitor of NS5B polymerase of 
Hepatitis C virus has also been shown to be effective against ZIKV infected 3 day old 
Swiss mice model, but still this a pregnancy category B drug which does not have well-
documented studies in humans (22). With these limitations in hand, in the present study, 
we tested the novel protective role of palmitoleate against ZIKV-induced trophoblast 
apoptosis. Palmitoleate (16:1 n-7) is an omega-7¸ monounsaturated fatty acid and has 
been shown to protect against saturated free fatty acid-induced apoptosis of hepatocytes, 
pancreatic beta cells, and umbilical vein endothelial cells (23-25). This led to our 
hypothesis that palmitoleate prevents ZIKV-induced ER stress and apoptosis in 
trophoblasts. Our results reveal that palmitoleate protects trophoblasts from ZIKV-
induced ER stress and apoptosis by downregulating the levels of ER stress markers such 





3.3 Materials and Methods 
 
Materials: Palmitoleate (#P9417), palmitate (#P5585), fatty acid free BSA (A3803), 
Steriflip vacuum  (#SCGP00525), 4’, 6-diamidine-2-phenylindole dihydrochloride 
(DAPI) (#D9542), and anti-flavivirus group antigen antibody (D1-4G2-4-15 clone) (# 
MAB 10216) were purchased from MilliporeSigma, MO ,USA.  Apo-ONE homogenous 
caspase 3/7 assay (WI # G7791) was obtained from Promega, Madison, WI, USA. 
Alexaflour-488 conjugated anti-mouse antibody (#A11001), Trizol Reagent (# 
15596018), Superscript II reverse transcriptase, (#18064-014), RNAse out (#10777-019), 
Random Hexamers (#8080127) were obtained from Thermo Scientific, MA and QIAamp 
viral-RNA isolation kit was from Qiagen, Hilden, Germany (#52906). Hydrolysis probe 
(Taqman) for Viral E protein detection were custom synthesized by IDT, IA, USA. 
Restriction enzyme, Pst I was from New England Biolabs, Ipswich, MA, USA (MA 
#R0140).  
Cells: JEG-3 and JAR cells, human choriocarcinoma-derived third trimester trophoblast 
cell lines, HTR-8SV/neo (HTR-8), a first trimester human immortalized trophoblasts, and 
Vero cells were used. MEM for JEG-3 cells and DMEM for JAR and HTR-8 cells 
containing 10% fetal bovine serum and 0.01 % plasmocin was used for. Vero cells were 
used for plaque assay and cultured in DMEM (Gibco, Waltham, MA, USA) containing, 
sodium bicarbonate (3.7g/L), 1X penicillin and streptomycin, 10% FBS, and 0.01% 
plasmocin. All the cells used in the present study were obtained from ATCC and 




Virus and infection of the trophoblasts: Original Ugandan MR766 strain (MRV) or 
recombinant MR strain of Zika virus (r-MRV) (26)  or PRVABC59 (PRV, Asian lineage 
isolated from Puerto Rico) were used to infect the cells with 0.1 -1 MOI. Virus infection 
media containing 2X DMEM (Gibco), 2% fetal bovine serum,100 µg/mL streptomycin, 
100 I.U./mL penicillin, 7.5% sodium bicarbonate, 20mM HEPES, sodium pyruvate, 1X 
nonessential amino acids and 0.01% plasmocin was used. After virus adsorption, the 
media was replaced with DMEM or MEM containing 10% fetal bovine serum and 1% 
BSA. 
Treatment of fatty acids: Palmitoleate and palmitate were dissolved in isopropanol with 
a stock solution concentration of 80 mM. Fatty acid-free BSA (1%) was dissolved in 
growth media at room temperature using a tube rotator and incubated at 37ᵒC for 30 
minutes in a water bath and then filter sterilized. Fatty acids were then incubated in the 
freshly prepared 1% fatty acid-free BSA for fatty acid-BSA conjugation by incubating at 
37ᵒC in the water bath for 20 minutes. We have used 100-200 µM concentrations of fatty 
acids for 48-96 hpi.  
Biochemical and structural characterization of apoptosis: Structural and biochemical 
markers of apoptosis like percent apoptotic nulcei and caspase 3/7 activity, respectively 
were assessed. Percent apoptotic nuclei was quantified by characteristic nuclear 
morphology and visualized by treatment with the fluorescent DNA-binding dye, DAPI as 
described (27). Briefly, cells were stained with 5 μg/mL of DAPI for 5-10 minutes at 
37°C. Apoptotic nuclei (condensed, fragmented) were counted and presented as a percent 
of total nuclei. At least 100 cells were counted per well and experiments were performed 




aspartyl-L-glutamyl-L-Valyl-aspartic acid amide (Z-DEVD-R110) substrate. The caspase 
3 and 7 enzyme activity in the cells will cleave the DEVD peptide in the substrate and 
release the rhodamine 110 fluorophore, which can be measured spectrofluorometrically 
(Biotek Synergy, Winooski, VT, USA) with 498nm wavelength of excitation and 521nm 
emission. The data were reported as fold-change of net fluorescence compared to vehicle 
treated cells, with experiments performed in triplicate or quadruplicate. 
Immunofluorescence analysis: After 48h of ZIKV infection, the media was aspirated 
and the cells were washed with phosphate buffered saline (PBS). Fixing was done with 
methanol and acetone at the ratio of 1:1 and washed thrice with PBS. Primary antibody, 
anti-flavivirus group antigen antibody (D1-4G2-4-15 clone) was used at a dilution of 
1:500 and incubated at room temperature for 2h with gentle rocking. After primary 
antibody incubation, cells were washed thrice with PBS in 5 minutes intervals. 
Alexaflour-488 conjugated anti-mouse antibody (Invitrogen, Carlsbad, CA, USA) was 
added at a dilution of 1:1000 and kept in a shaker at room temperature for 1h. After 
incubation the cells were washed thrice in PBS and then visualized under Nikon A1R-Ti2 
confocal system. 
Quantitative real time Polymerase Chain Reaction: Total RNA was extracted from 
cells, 48-96 hpi using TRIzol reagent as described in the manufacturer protocol. Around 
1-5µg RNA from each sample was reverse transcribed to cDNA using random hexamers, 
RNAse OUT and Superscript II. Relative CHOP mRNA expression was quantified using 
Light cycler 480 SYBR Green I Master Version 13 (Roche, Basel, Switzerland) in a Bio-




as described (28) was used. Housekeeping gene 18S rRNA was used as control and the 
primer used are listed in table 3.1.  
Table 3.1 Primer details 
 
Quantification of viral RNA copy number using hydrolysis probe: RNA form cell 
culture supernatant was isolated by QIAamp viral-RNA extraction kit. RNA from cell 
lysate was isolated by TriZOL and cDNA synthesis was performed. Taqman hydrolysis 
Primer Forward 
primer 








unspliced forms ~474bp 
cleaved by the restriction 
endonuclease (PstI) - two 
products are around 296bp 
and 183bp are formed 
spliced forms lack restriction 




























for viral E 
gene 
5′-/56-FAM (5′ 6-carboxyfluorescein)/AGCCTACCT/ZEN/TGACAA





probes for quantitative PCR primers targeting E gene of the ZIKV was used (Table 3.1). 
Absolute RNA quantification was performed using a standard curve generated from PCR 
product using primers listed in table 3.1 and as described (6). 
XBP1 mRNA splicing assay: 
The cDNA samples with 1:3 or 1:10 dilution was subjected to PCR to amplify XBP1 
gene using the primer set (each 20µM)  as described (29). The PCR product (around 
8 µL) was digested with 1µL of PstI (20 U) in 1 µL of 3.1 NEB buffer containing 100 
mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2, 100 µg/mL BSA pH 7.9 and incubated at 
37oC for 2h. The restriction enzyme digested PCR product was electrophoresed in 2% 
agarose gel stained with ethidium bromide. The unspliced 474 bp nucleotide and can be 
cleaved by PstI enzyme by recognition of the intact restriction site, resulting in 296 bp 
and 183 bp fragments. The spliced forms lacks the intact restriction enzyme site so the 
bands are visualized around 448bp. GAPDH was used as a control and was amplified 
using primers listed in table 3.1 (30). Relative band intensities were analyzed using 
Image J software.  
Western blot: Cell lysates  were scrapped using 100µL of lysis buffer made of 50mM 
Tris pH 7.4, 150mM NaCl, 1mM EDTA, 1mM DTT, 1mM Na3Vo4, 1mM PMSF, 
100mM NaF and 1% Triton x-100 . Cell supernatant obtained after 10,000 x g for 10 min 
of centrifugation and was used for protein estimation using modified Lowry method-
Pierce 660nm protein assay reagent (ThermoFisher Scientific). Around 30µg protein was 
electrophoresed in a 10% SDS-polyacrylamide gel and transferred into nitrocellulose 




used in 1:1000 dilution in with 5% BSA in TBST. Secondary antibody was used in 
1:5000 dilution.  Washes of 10 mins each for 3 times were employed after both primary 
and secondary antibody incubation.  The blot was developed using Clarity Western ECL 
substrate (Bio-Rad, Hercules, CA, USA).  
Plaque assay: The plaque assay was performed as described (31). Briefly, cell culture 
supernatants were collected after 48 h of ZIKV infection and fatty acid treatment (48hpi) 
and diluted serially 10-3 to 10-4 using virus infection media in duplicates. The diluted 
supernatant samples were kept for virus adsorption for 1 h over 90% confluent Vero cells 
and the cells were washed with PBS prior to virus adsorption. After virus adsorption 1:1 
ratio of 2% low melting agarose and plaque assay media containing 2x DMEM, 1X 
penicillin and streptomycin, 4% FBS, sodium bicarbonate 7.5%, 20mM HEPES, sodium 
pyruvate, 1X nonessential amino acids and 0.01% plasmocin were added to each well and 
incubated at 37oC for 4 days. Fixation of cells was done by using 10% Formalin in PBS 
for 1h. After the removal of agarose overlaid in each well, fixed cells were stained with 
0.1% crystal violet staining solution for 1h followed by washing the plates with distilled 
water and allowed to air dry. Plaques were counted in each well and expressed plaque 
forming units/mL (pfu/mL).  
Percent Cell Survival using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide (MTT): Stock solution containing 50mg of MTT in 10 mL of PBS was filter 
sterilized and stored at 4oC. Around 20 µL of MTT stock was diluted to 100 in MEM 
media without any FBS. Media from the cells grown in a 96 well plate was aspirated and 
then 110 µL of the prepared MTT solution was added to each well. After 4h incubation at 




mL of isopropanol was added to each well. The contents were gently mixed and the 
absorbance was measured at 540 nm.  
Assessment of cell viability using crystal violet: The assay was performed as described 
by (32).  Briefly, In a 24 well plate 30,000 cells were seeded and infected with ZIKV and 
fatty acids were treated after 1 h of virus adsorption.  After 48h, media was aspirated and 
washed two times with double distilled water. The cells were then stained with 300µL of 
0.5% crystal violet staining solution per well for 20 mins at room temperature with gentle 
rocking. The excess stain after incubation was washed four times with double distilled 
water and air dried for 2h by inverting the plate onto a blotting paper. Once the plate was 
dried, around 500of methanol was added to each well and placed on a rocker for 20 mins 
at room temperature and the absorbance was measured at 570nm. 
2.14. Data analysis: Data are expressed as mean ± standard error of mean (SEM). 
Statistical analysis was performed using Welch’s t test, P value <0.05 was considered as 
statistically significant.  
3.4 Results 
Palmitoleate prevents ZIKV-induced placental trophoblast apoptosis: We observed 
the characteristics apoptotic nuclear morphological changes in ZIKV-infected placental 
trophoblasts, and showed a dramatic increase in percent apoptotic nuclei after 1.0 MOI of 
PRV infection for 48-96 h in JEG-3 cells (Fig.3.1A, B, and Supplementary Fig.1A). 
Percent apoptotic nuclei was significantly reduced with the treatment of 100-200µM of 
palmitoleate after 1 MOI of PRV infection for 48-96h in JEG-3 cells compared ZIKV 




infected trophoblasts with palmitoleate significantly downregulated caspase 3/7 activity 
after 48-72 h of infection compared PRV infection alone in JEG-3 cells (Fig.3.1A, B).   
 
Fig.3.1. Palmitoleate treatment after Zika virus (ZIKV) PRVABC59 strain (PRV) 
infection inhibits apoptosis in JEG-3 cells.  
(A) Structural and biochemical characterization of apoptosis in JEG-3 infected with 1.0 
MOI (multiplicity of infection) ZIKV PRV strain, 48-72 h showed increase in percent 
apoptotic nuclei compared to uninfected vehicle cells. Infected cells treated with 100µM 
or 200µM of palmitoleate, 48-72hpi (hours post infection) showed a decrease in the 
percent apoptotic nuclei when compared to ZIKV infected cells alone (left panels). (B) 
There was a significant activation of caspase 3/7 in ZIKV infected cells, but caspase 3/7 
activation was significantly blocked when the infected cells were treated with 100 or 
200µM of palmitoleate both at 48 and 72 hpi (right panels). Data represents mean ±SEM, 






Supplementary Fig.1. (A) Increase in percentage apoptotic nuclei in JEG-3 cells 
infected with 1.0 MOI PRV 96hpi when compared to uninfected vehicle cells. On 
treatment with 100-200 µM palmitoleate post infection there was significant reduction in 
the percent apoptotic nuclei. (B) Similarly, there was significant upregulation of caspase 
3/7 in 1.0MOI PRV infected JAR cells when compared to uninfected vehicle cells but 
this was significantly downregulated when the cells were treated with 100-200 µM 
palmitoleate post infection. Data represents mean ±SEM, n=3.*P<0.05 compared to 
uninfected vehicles cells, #P<0.05 compared to ZIKV infected cells. 
We next tested the protective role of palmitoleate in another human term-derived 
placental trophoblast (JAR cells) using MRV, original Ugandan strain for 48h. JAR cells 
infected with MRV showed dramatic increase in the number of cells that show 
fragmented and condensed nuclei compared to vehicle cells. Increased nuclear 




(100-200 µM, Fig.3.2A). Further, increased percent apoptotic nuclei observed in 1.0 MOI 
MRV infection was dramatically reduced with the treatment of 100 and 200µM 
palmitoleate in JAR cells (Fig.3.2 A-B). We also observed a significant decrease in 
caspase 3/7 activity with 200 µM palmitoleate treatment and a trend in decreased caspase 
3/7 activity with the 100 µM palmitoleate treatment in 1.0 MOI MRV infected 
trophoblasts (Fig.3.2C). Similarly, JAR cells infected with 1.0 MOI of PRV also showed 
increased caspase 3/7 activity and this was prevented with the treatment of 100-200 µM 
palmitoleate (Supplementary Fig. 1B).  
To test whether palmitoleate would also protect against first-trimester derived placental 
trophoblast cells, we used HTR-8 cells. Similar to JEG-3 and JAR cells, HTR-8 cells 
showed enhanced apoptosis as evidenced by an increase in the levels of percent apoptotic 
nuclei and caspase 3/7 activity with 1.0 MOI of r-MRV for 72h (Fig.3.2D). Treatment of 
100 and 200µM palmitoleate to 1.0 MOI of r-MRV infected HTR-8 cells significantly     









           
              
Fig.3.2. Treatment of the placental cells with palmitoleate after MR766 strain of 
ZIKV infection inhibits apoptosis.  
(A) Phase contrast (left panels) and DAPI stained (right panels) image panels: 
Characteristic nuclear morphological changes were detected with DAPI staining in third 
trimester-derived JAR cells after 48 hpi with MRV. Vehicle cells show little to no DAPI 
staining. Infected panel shows higher number of DAPI stained fragmented and condensed 
nuclei compared to 100 or 200µM pamitoleate treated cells. The images shown here are 
representative images. (B) JAR cells infected with 1.0 MOI MR strain of ZIKV showed 
increase in the percentage apoptotic nuclei when compared to uninfected vehicle cells. In 
cells treated with 100µM and 200µM palmitoleate 48 hpi showed a significant decrease 
in the percent apoptotic nuclei compared to ZIKV infected cells. (C) There was a 
significant increase in caspase 3/7 activity in MRV infected cells, but this was 
significantly blocked when the cells were treated with 200µM of palmitoleate post 
infection and a trend towards downregulation at 100µM pamitoleate treatment in the 
MRV infected cells. (D) Characteristic nuclear morphological changes were detected 
using DAPI staining in first trimester derived HTR-8 cells after 72 hpi were calculated 
and represented as percent apoptotic nuclei. Cells infected with 1.0 MOI r-MR strain of 
ZIKV showed increase in the percent apoptotic nuclei when compared to uninfected 
vehicle cells. However, cells treated with 100µM and 200µM palmitoleate post infection 
showed a significant decrease in the percentage apoptotic nuclei compared to ZIKV-
infected cells. (E) There was an increase in caspase 3/7 activity in infected cells when 
compared to uninfected vehicle cells but this activation was significantly blocked when 




mean ±SEM, n=3 for percent apoptotic nuclei and n=4 for caspase 3/7 activity.*P<0.05 
compared to uninfected vehicles cells, #P<0.05 compared to ZIKV infected cells. 
 
 
Treatment of palmitoleate to ZIKV infected trophoblasts reduces viral RNA copy 
number: JAR cells were infected with MRV for 72 h and palmitoleate treatment (100 
and 200µM) showed a dramatic decrease in the Zika viral (E gene) RNA copy number in 
cell culture supernatant with both 0.1 and 1 MOI and a trend towards decrease in cell 
lysate (Fig.3.3A and 3.3C). This suggests that palmitoleate interferes with ZIKV 
replication and its release from infected placental trophoblasts. Similarly, HTR-8 cells 
infected with MRV for 96h showed significant reduction in viral envelope RNA copy 
numbers with the treatment of palmitoleate (100 and 200µM) with 1 MOI infection and a 
trend towards reduction with 0.1 MOI in cell culture supernatant (Fig.3.3B). Palmitoleate 
treatment with both 0.1 and 1 MOI in HTR-8 cells showed only a trend towards reduction 














Fig.3.3. Treatment of the placental cells with palmitoleate after ZIKV infection 
interferes with viral replication.  
Presence of viral envelope RNA copy number in the cell culture supernatant of both (A) 
JAR and (B) HTR-8 cells infected with 0.1 and 1.0 MOI of ZIKV MR766 strain 72h and 
96 hpi respectively. When MRV infected cells were treated with palmitoleate (100-
200µM), there was significant reduction in the viral envelope RNA copy number in the 
cell culture supernatant with both 0.1 and 1 MOI in JAR cells and with 1 MOI in HTR-8 
cells (A-B). Presence of viral envelope RNA copy number both in JAR (C) and HTR-8 
(D) cell lysate infected with 0.1 and 1.0 MOI of ZIKV MR766 strain 72 and 96 hpi 
respectively. When the infected cells were treated with 100-200µM of palmitoleate, there 
was a trend showing reduced viral envelope RNA per microgram of total RNA in both 
JAR cell lysate (C) and HTR-8 cell lysates (D). Data represents mean ±SEM, n=3. 
#P<0.05 compared to ZIKV infected cells. (E-G) Viral E protein staining in JEG cells 
infected with 0.1 MOI r-MRV and in cells treated with 100 or 200µM palmitoleate, 
48hpi. (E) ZIKV infected cells show green fluorescence indicating presence of viral E 
protein.  (F) ZIKV infected JEG-3 cells treated with 200µM palmitoleate and show a 
reduction in the intensity of viral E protein staining. (G) Infected JEG-3 cells treated with 
100-200µM palmitate showed increased intensity of viral E protein staining.  Nuclei were 
stained with DAPI. (H) Immunoblot analysis showed dramatic increase in viral E protein 
expression with ZIKV infection in JEG-3 cells compared to vehicle uninfected cells. 
Treatment of 200µM palmitoleate to ZIKV infected cells showed reduced viral E protein 
expression compared to the ZIKV infected cells alone. 
 
Immunofluorescence analysis of Zika Viral E protein: We, next tested the expression 
of viral E protein in JEG-3 cells 48 hpi with 0.1MOI of r-MRV. There was an increase in 




compared to the uninfected vehicle cells (Fig.3.3E). The viral E protein expression was 
dramatically reduced in JEG-3 cells treated with palmitoleate (200µM) 48 hpi compared 
to ZIKV infected cells alone. The viral E protein expression was dramatically increased 
in JEG-3 cells treated with palmitoleate (100µM) 48 hpi and palmitate (100-200µM) 
(Fig.3.3F). The number cells in the 200µM palmitate treated cells was significantly less 
which was comparable to infected cells alone (Fig.3.3G). Western blot analysis of JEG-3 
cells infected with 0.1 MOI r-MRV showed dramatic increase in viral E protein and 
treatment of 100- 200 µM palmitoleate showed a decrease in viral E protein expression. 
Treatment of palmitate (100-200µM) did affect the viral E protein expression 48 hpi 
(Fig.3.3H). Similarly, there was non-significant decrease in pfu/mL in cell culture 
supernatant from 200µM palmitoleate treated cells for 48hpi in JEG-3 cells. Palmitate 
treatment at 100 or 200 µM concentration altered JEG3 viral load in cell cuture 
supernatant (Supplementary figure 2A). Palmitoleate treatment (100-200µM) in JEG-3 
cells after infection with 0.1 MOI r-MRV showed a non-significant decrease in viral (E 
gene) RNA copy number in cell lysate. We also observed a non-significant decrease in 
viral E gene RNA copy number in the cell lysate with 100µM palmitate treatment. 
However, JEG-3 cell lysate after 200µM palmitate treatment to 0.1 MOI r-MRV infected 
cells showed a significant reduction in the viral RNA copy number compared to ZIKV 






Supplementary Fig.2. (A) Plaque assay using cell culture supernatant showed a trend in 
decreased pfu/ml in 200 µM palmitoleate treated +ZIKV infected cells. Treatment of 100 
µM palmitate for 48h with 0.1 MOI r-MRV infected cells showed a trend towards 
increase in pfu/ml but in contrast 200µM palmitate treatment showed a trend towards 
reduction in pfu/ml. Data represents mean ±SEM, n=3. #P<0.05 compared ZIKV infected 
cells. (B) Similarly, viral envelope copy number in cell lysate with 200 µM palmitoleate 
treatment showed a trend towards reduction when compared 0.1 MOI r-MRV infected 
cells alone but 200µM palmitate treated cells showed a significant reduction in the viral 
envelope RNA  copy number 48hpi. Data represents mean ±SEM, n=3. #P<0.05 




Palmitate does not protect against ZIKV-induced ER stress and apoptosis: 
Treatment of JEG-3 cells with palmitate, a saturated fatty acid, after ZIKV infection 
either with r-MR or PR strains did not protect against ZIKV-induced trophoblast 
apoptosis (Fig.3.4). There was significant reduction in the percent apoptotic nuclei and 
caspase 3/7 activation with palmitoleate treatment and this protection was not observed 
with the treatment of palmitate. (Fig.3.4A-C). Additionally, treatment of palmitate to 
r-MRV infected JEG-3 cells caused significant increase in percent apoptotic nuclei levels 
compared to r-MRV infection alone (Fig.3.4A). These results suggest a unique protective 
property of palmitoleate against ZIKV-induced trophoblast apoptosis and that are not 





Fig.3.4. Palmitoleate protects against ZIKV-induced apoptosis but not palmitate.  
(A-B) There was significant reduction in (A) percentage apoptotic nuclei and (B) caspase 
3/7 activation in JEG-3 cells treated with palmitoleate 48hpi with 0.1 r-MRV suggesting 
the protective role of palmitoleate against ZIKV-induced apoptosis. When the JEG-3 
cells were treated with palmitic acid 48hpi, there was significant increase in the percent 
apoptotic nuclei and a trend towards increase in caspase 3/7 activation suggesting that 
palmitate did not protect against ZIKV-induced apoptosis. Data represents mean ±SEM, 
n=3 for percentage apoptotic nuclei and n=4 for caspase 3/7 activity.*P<0.05 compared 
to uninfected vehicles cells, #P<0.05 compared ZIKV infected cells. (C) Similarly, in 
JEG-3 cells with 1.0 MOI of PRV for 48h the percent apoptotic nuclei was significantly 
reduced in 100-200 µM palmitoleate treated PRV infected cells compared to ZIKV 
infected cells alone, however treatment of palmitate to ZIKV infected cells did not 
prevent ZIKV-induced apoptosis. Data represents mean ±SEM, n=3.*P<0.05 compared 
to uninfected vehicles cells, #P<0.05 compared to ZIKV infected cells. 
 
Palmitoleate improves cell viability in ZIKV infected trophblasts: The percent cell 
survival measured using crystal violet shows a significant reduction in the percent cell 
survival with 0.1 MOI r-MRV infection in JEG-3 cells, 48 hpi when compared to 
uninfected vehicle cells. The percent cell survival was significantly increased with the 
treatment of 100 or 200µM palmitoleate post infection and this protection was not 
observed with the treatment of palmitate after ZIKV infection (Fig.3.5A). Similarly, the 
percent cell survivability assessed using MTT also showed significant reduction in cell 
survival with 0.1 MOI r-MRV in JEG-3 cells when compared to uninfected vehicle cells. 
Treatment of palmitoleate to JEG-3 cells infected with 0.1 MOI r-MRV showed a 
significant increase in cell survivability with 200 µM concentration wheras as 100 µM 
concentration showed a non-significant increase in percent cell survival. Surprisingly, 
palmitate treatment in infected cells at 200µM concentration showed a slight but 






Fig.3.5. Palmitoleate improves cell viability in ZIKV infected cells.  
(A) The percent survival using crystal violet assay was significantly reduced with 
0.1MOI r-MRV when compared to uninfected vehicle cells. The percent cell survival was 
significantly increased with 100 or 200µM of palmitoleate treatment, but not seen 
with100-200µM palmitate treatment 48hpi. (B) The percent cell survivability using MTT 
showed significant improvement in cell survivability with 200 µM palmitoleate treatment 
in ZIKV-infected cells. Whereas 200µM palmitate treatment in ZIKV infected cells also 
showed a significant increase in cell survivability. Data represents mean ±SEM, n=3 for 
percent cell viability using crystal violet assay and n=4 for MTT assay. *P<0.05 
compared to uninfected vehicles cells, #P<0.05 compared to ZIKV infected cells. 
 
Palmitoleate protects against ZIKV-induced endoplasmic reticulum (ER) stress: We 




levels of C/EBP homologous protein (CHOP) mRNA and Spliced X box associated 
protein-1 (XBP1) mRNA, which are key markers of ER stress (30). We assessed the 
activation of ER stress markers namely CHOP mRNA expression and XBP1 gene 
splicing with palmitoleate or palmitate treatment  to ZIKV-infected JEG-3 cells. We 
observed a significantly higher levels of CHOP mRNA expression with 0.1 MOI r-MRV 
infection in JEG-3 cells, 48 hpi compared to uninfected vehicle cells. Treatment of 
palmitoleate at 200 µM final concentration to the ZIKV-infected cells showed a 
significant reduction in the expression of CHOP. However, treatment of 100 µM 
palmitoleate showed only a trend towards decrease in CHOP mRNA expression 
compared to ZIKV-infected cells (Fig.3.6A). Whereas, treatment of 100 or 200 µM 
palmitate to ZIKV infected cells did not significantly decrease the expression of CHOP 
(Fig.3.6A). We next investigated XBP1 mRNA splicing levels (~448 bp band) which is 
an additional indicator of ER stress in cells. Spliced XBP1 mRNA levels were elevated 
with 0.1 MOI r-MRV infection in JEG-3 cells compared to uninfected vehicle cells. 
Palmitoleate treatment (100 or 200 µM) was able to reduce the extensive XBP1 mRNA 
splicing seen in the ZIKV infected cells. However, treatment of palmitate did not prevent 
the increased levels of spliced XBP1 caused due to ZIKV infection (Fig.3.6B). The 
relative band intensity of spliced XBP1 showed a significant increase in percent ratio of 
spliced XBP1/GAPDH in ZIKV infected cells when compared to uninfected vehicle 
cells. There was a trend towards increase in spliced XBP1/GAPDH in palmitate treated 
cells compared to ZIKV infection alone. However, supplementation of palmitoelate 
signicantly decreased  percent ratio of spliced XBP1/GAPDH (Fig.3.6C). A trend 




palmitoleate treated ZIKV infected cells when compared to ZIKV infected cells alone or 
ZIKV infected cells treated with palmitate (Fig.3.6D). Thus, treatment of palmitoleate 







Fig.3.6. Palmitoleate protects against ZIKV-induced ER stress but not palmitate.  
(A) CHOP mRNA expression was significantly upregulated with 0.1 MOI r-MRV 48hpi 
in JEG-3 cells compared to uninfected control cells. There was significant reduction in 
CHOP mRNA expression in JEG-3 cells treated with 200µM palmitoleate 48hpi with 
ZIKV suggesting protective role of palmitoleate against ZIKV-induced apoptosis and a 
trend towards decreased expression with 100µM palmitoleate treatment but this was not 
seen with the treatment of 100 or 200µM palmitate to r-MRV infected cells. (B) 
Similarly, there was increase in XBP1 mRNA splicing in infected cells (band ~448bp) 
when compared to uninfected vehicle cells. There was significant inhibition of XBP1 
mRNA splicing with the treatment of 100 or 200µM of palmitoleate in ZIKV infected 
cells. However the protective properties was not seen with the treatment of palmitate to 
ZIKV infected cells. (C) Quantified levels of spliced XBP1 mRNA (448 bp) relative to 
GAPDH (Spliced XPB1/GAPDH). (D) Quantified levels of unspliced XBP1 mRNA 
(474bp) relative to GAPDH (Unspliced XPB1/GAPDH). Data represents mean ±SEM, 
n=3. *P<0.05 compared to uninfected vehicles cells, #P<0.05 compared to ZIKV infected 
cells. 
3.5 Discussion 
Zika virus is known to cause apoptosis via sustained ER stress in the trophoblasts (30). 
The principal findings of the present study are 1) palmitoleate, an omega 7 
monounsaturated fatty acid significantly reduces ZIKV infection-induced trophoblast 
apoptosis; 2) treatment of palmitoleate interferes with ZIKV replication in trophoblasts; 




activation of ER stress markers that occurs due to viral protein overload, and 4) palmitate, 
a saturated fatty acid with similar carbon structure to palmitoleate augments cell death in 
ZIKV-infected trophoblasts. The schematic representation of palmitoleate protection 
against ZIKV-induced trophoblast apoptosis is shown in Figure 3.7.  
 
Fig.3.7. The schematic diagram represents palmitoleate protection against ZIKV-
induced ER stress and apoptosis in placental trophoblasts. 
ZIKV infection in trophoblasts elicits ER stress via the upregulation of CHOP and XBP1 
mRNA splicing which in turn activates apoptosis. Supplementation of palmitoleate 
protects against ZIKV-induced ER stress and trophoblast apoptosis. 
 
ZIKV infection from mother to the developing fetus is detrimental in causing Congenital 
Zika Syndrome (4). Trophoblasts, the epithelial cells of the placenta express receptors 
such as AXL, Tyro3, and TIM1 that facilitate the entry of ZIKV into these cells (33,34). 
ZIKV infection of Infar1 knock out mice shows that ZIKV is able to breach the placental 




in, immunocompetent mouse model shows that a mouse adapted ZIKV strain belonging 
to African lineage was able to cross the placental barrier and blood brain barrier (35). 
Therefore, transplacental route of transmission from mother to the fetus plays a crucial 
role in the disease process (36,37). In our previous study, we have shown that ZIKV 
induces a caspase-dependent trophoblast apoptosis as evidenced by significant increase in 
percent apoptotic nuclei and caspase 3/7 activation following ZIKV infection. Further, 
inhibition of caspases activity using Z-VAD-fmk prevented ZIKV-induced placental 
trophoblast apoptosis (30). ZIKV is also known to cause changes in the sphingolipid 
metabolism in the host cells. Ceramide, a sphingolipid is already known to be associated 
with apoptosis and have been found to be essential for ZIKV replication cycle in the host 
cells (38,39). Ceramides are also known cause ER stress and affect overall lipid 
metabolism in hepatocytes (40). However, protective role of palmitoleate 
supplementation against ZIKV-induced ER stress and apoptosis via alteration of 
sphingolipid metabolism needs further investigation. 
There are several potential vaccine candidates, therapeutic drugs and nutraceutical 
compounds under investigation for protection and treatment against ZIKV infection (41-
45). Since the prospective target population who needs protection during outbreaks 
involves pregnant women, this poses challenges regarding the safety of the vaccine 
candidates or the drugs that can ensure safety to both the mother and the developing baby 
without any adverse reactions (46-50). In contrast, nutrient compounds can be an 
alternative strategy to combat viral infections in the context of safety during pregnancy. 
For example, 25-hydroxy cholesterol, an oxysterol metabolite, which plays a critical role 




against ZIKV-induced microcephaly in type I interferon α/β receptor knockout (Infar-/-) 
mice (51). In an another study, it was observed that natural polyphenols like delphinidin 
and epigallocatechin gallate have anti-viral properties against flavivirus including ZIKV 
(52). Curcumin, a polyphenol present in turmeric tubers was also found to inhibit the 
attachment of ZIKV to the host cells (53). Naringenin, a flavonoid compound seen in 
citrus fruits had anti-viral properties against ZIKV infection by interacting with the 
protease domain of the virus (54).  In the present study, we have established the 
protective role of palmitoleate against ZIKV-induced apoptosis in placental trophoblasts 
in an in vitro model.  
Palmitoleate (16:1 n-7) is rich in dietary sources such as sea buckthorn oil and 
macadamia nuts (55). In mammals, palmitoleate can be synthesized by stearoyl‐CoA 
desaturase 1 (SCD1) enzyme from the saturated fatty acid, palmitate (56). Palmitoleate is 
abundant in adipose tissue, blood cells and it is a part of cell membrane structure (57). 
Palmitoleate plays an important role in maintaining metabolic health and homeostasis by 
acting as a lipokine (58). Palmitoleate decreases fat deposition in liver and enhances 
insulin sensitivity (57).  Studies have shown that palmitoleate protects against free fatty 
acid-induced hepatocyte lipoapoptosis (23) and trophoblast lipoapoptosis (59), 
respectively.  Supplementation of palmitoleate has shown to be effective against non-
alcoholic fatty liver disease and atherosclerosis in mouse models (60,61). Palmitoleate 
can skew pro-inflammatory state to anti-inflammatory state of macrophages in mice fed 
with high fat diet via AMP activated protein kinase signaling (62). Previous studies also 
suggest that monounsaturated fatty acids such as palmitoleate and oleate inhibit 




also been shown to protect against tunicamycin- and palmitate-induced ER stress and 
apoptosis in hepatocytes and pancreatic beta cells, respectively (23,24). Our data in the 
present study supports the protective role of palmitoleate against ZIKV-induced ER stress 
and apoptosis in placental trophoblasts and therefore could likely serve as a therapeutic 
candidate or preventive nutrient compound for ZIKV infection in pregnant mothers in 
disease infection prone areas.  
Our data shows a proof that palmitoleate prevents ZIKV-induced trophoblast apoptosis. 
We also saw reduction in viral RNA copy number in the cell culture supernatant from 
JAR (0.1 and 1MOI) and HTR-8 (1 MOI) infected cells following palmitoleate treatment. 
On the other hand we saw a trend towards reduction viral RNA copy number in both JAR 
and HTR-8 cell lysate, this could be due to the fact that viral particles were already 
released from the cells to the culture supernatant. We also saw reduction in the 
expression of viral E protein in JEG-3 cells infected with 0.1 MOI r-MRV and with a co-
treatment of 200µM palmitoleate. Similarly, 200µM palmitoleate treatment showed 
improved cell survivability and reduced viral E protein staining, further suggests that it 
could interfere with the viral replication. Viral E protein in ZIKV also has a lipid 
component and might also possibly be altered with palmitoleate treatment, which require 
further investigations. 
Although we saw significant reduction in viral E gene copy number in 200µM palmitate 
treated JEG-3 cell lysate, this might be due to the fact that there is less viable cells for 
viral replication in palmitate treated cells as observed in apoptotic nuclei and cell 
viability assay.  The MTT assay measures active mitochondrial dehydrogenase and we 




whereas palmitate treatment to ZIKV infected cells resulted in intact mitochondrial 
enzyme activity. Further, to substantiate this phenomenon a recent study suggests that 
low levels of palmitate supplementation can increase mitochondrial function (65). Also 
the use of crystal violet for cell viability assessment has been shown to be more reliable 
than MTT assay (66).  
ZIKV is also known to alter the lipid homeostasis of the placenta by altering the 
organelles in the cells by forming virus replicating complexes enclosed in vesicles. ZIKV 
also resulted increase in accumulation of large lipid droplets both in infected and 
uninfected bystander placental cells (15). However further studies are required to 
elucidate the mechanism behind the protective role of palmitoleate by affecting the viral 
replication. This could be possible through ways such as i) hindrance against Zika viral 
entry receptor binding; ii) E protein lipid component; or iii) inhibition of specialized viral 
replication complex are warranted. 
Studies have shown that palmitate, a saturated fatty acid can either promote viral 
infection (67) or have anti-viral properties (68) via autophagy flux mechanism. We found 
that palmitate treatment augmented apoptosis in ZIKV infected trophoblasts. A study 
using Influenza A virus model showed that palmitate supplementation to the cells can 
enhance viral replication (69). Similarly, Rift Valley Fever virus-infected cells were 
shown to activate AMP-activated protein kinase (AMPK) and decreases viral replication 
by limiting fatty acid synthesis, treatment of palmitate helped in initiating fatty acid 
synthesis and aids in replication of the Rift Valley Fever virus (70). In our study, 
palmitate treatment to ZIKV infected cells reduces the cell viability and probably 




Palmitoleate is known to activate cell survival pathways and has been shown to protect 
against metabolic syndrome (57). Palmitoleate plays a protective role by modulating 
peroxisome proliferator-activated receptor alpha (PPARα), an important transcription 
factor that regulates fatty acid oxidation by activating AMPK which in turn improves 
glucose metabolism in liver cells of mice fed with high fat (56,71). Further, post-
translational modification of Wnt protein with palmitoylation results in a signaling 
pathway that activates β-catenin, a cell survival signal (72,73). Several studies have also 
shown that palmitoleate supplementation helps in improving metabolic diseases in 
humans such as cardiovascular diseases and diabetes mellitus (74,75). Our results study 
suggests that palmitoleate treatment in ZIKV infected trophoblasts is protective against 
ER stress and apoptosis, thereby considerably improves cell survival. However further 
mechanistic studies are underway in elucidating the protective role of palmitoleate 
against ZIKV-induced trophoblast apoptosis.  
3.6 Conclusion 
Palmitoleate is protective against ZIKV-induced ER stress and apoptosis in trophoblasts. 
The mechanism of palmitoleate protection against ZIKV-induced ER stress and apoptosis 
is either via direct interference of viral replication or by the activation of cellular survival 
pathways or a combination of both, requires which needs further investigations.  
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CHAPTER 4: PROTECTIVE ROLE OF PALMITOLEATE AGAINST ZIKA 
VIRUS-INDUCED INFLAMMATION IN PLACENTAL TROPHOBLASTS 
4.1 Abstract 
Zika virus (ZIKV) is known to cause an inflammatory response in the brain, retina and 
placenta. The production of excessive inflammatory cytokines can be detrimental to fetal 
development. ZIKV infection also triggers inflammasome activation to exploit 
inflammatory pathways, thereby evades immune responses by the host. In this study, we 
explored the protective role of palmitoleate against inflammatory response in ZIKV 
infected trophoblasts. The pro-inflammatory cytokine IL-1β mRNA expression was 
significantly downregulated in 200µM palmitoleate-treated trophoblasts after ZIKV 
infection. We also found that lipid droplet accumulation was higher in ZIKV infected 
cells with palmitoleate treatment when compared to palmitate treatment in ZIKV infected 
cells or ZIKV infection alone. Further studies are required to elucidate the protective 
properties of palmitoleate against ZIKV-induced inflammatory response in trophoblasts. 
4.2 Introduction 
ZIKV is known to induce an inflammatory response in the nervous system, the eye, the 
placenta, and the male and female reproductive organs (1-5). ZIKV infection in the 
human placenta causes extensive alterations in lipid metabolism to favor its replication 
along with the inflammatory response (3). ZIKV infected adult populations can develop 
neurological problems associated with inflammation including Guillain-Barre syndrome, 
chronic inflammatory demyelinating polyneuropathy, acute transient polyneuritis, 





(6). ZIKV induced inflammatory response is mainly attributed to IL-1β secretion 
associated with NLRP-3 inflammasome activation (7). ZIKV uses NLRP-3 inflammatory 
pathway via NS-1 to thwart the host’s immune response against it (8). IL-22 was found to 
be a key cytokine that impedes cell-mediated immune responses against ZIKV and 
aggravates inflammation of the brain in newborn mice (9). Another study in neonatal 
mice suggests that ZIKV persists in the central nervous system even after a year resulting 
in chronic inflammation (10).  
It is known that lipid droplet formation helps to prevent activation of 
inflammatory cell signaling pathways while lipolysis favors inflammatory response (11). 
It is also known that palmitoleate can modulate lipid metabolism by enhancing 
lipogenesis and fatty acid oxidation (12). Further, lipid droplet formation is known have a 
protective role against viral infection (13). In this study,  we hypothesize that 
supplementation of palmitoleate in ZIKV infected cells would increase lipid droplet 
accumulation and protect against ZIKV-induced inflammatory cytokine response. 
4.3 Materials and methods 
 
Materials:  
Adipose differentiation-related protein (ADRP) antibody (# 10R-A117ax) procured from 
Fitzgerald, MA. ZIKV E protein antibody was obtained from Gene Tex (# GTX133314), 
CA. Alexa flour 488 conjugated anti-rabbit antibody (# A11008) and Alexa flour 647 





O (#O0625) and saponin (#47036) were from Millipore Sigma, MO. Paraformaldehyde 
16% (#15710) procured from Electron Microscopy Sciences, PA.  
Quantitative Real time PCR: JEG-3 cells infected with 0.1 MOI r-MRV and treated 
with palmitoleate for 48h. TriZOL reagent (Thermo Scientific) was used to isolate RNA 
from the scrapped cells and subjected cDNA synthesis with superscript II reverse 
transcriptase (Invitrogen). Target IL-1β mRNA expression was amplified by primer and 
normalized with 18S rRNA expression using SYBR green assay as described by (14). 
Immunofluorescence analysis: Collagen-coated coverslips kept inside 24 well plates 
were used for JEG-3 cell attachment and treatment of the cells with fatty acids after 1 h 
of virus adsorption. After 48 h of incubation, cells were washed with PBS and fixed with 
3% paraformaldehyde solution containing 100mM piperazine-N, N′-bis(2-ethanesulfonic 
acid) (PIPES), 3mM MgSO4 and 1mM ethylene glycol-bis(β-aminoethyl ether)-N, N, N′, 
N′-tetraacetic acid (EGTA) for 30mins. After fixation cells were washed with PBS and 
permeabilization was done with 0.5% saponin (Millipore Sigma) in PBS for 10mins. 
Cells were once again washed with PBS and blocked using PBS containing 5% glycerol, 
5% FBS and 0.01% sodium azide for 30mins. Overnight incubation at 4oC with anti-
ADRP antibody (1:10) and antibody raised against ZIKV E protein (1:100) was done. 
Excess unbound antibody was washed away using PBS wash, 3 times. Anti-mouse 
secondary ab tagged with Alexaflour 647 (1:100) and anti-rabbit secondary ab tagged 
with Alexaflour 488 (1:500) were used for 2 h at room temperature. The cells were 





wash with PBS. The coverslips were carefully removed, blotted and mounted onto glass 
slides and visualized under Nikon A1R-Ti2 confocal system. 
Oil Red O staining: JEG-3 cells infected with 0.1r-MRV and treated with either 
palmitoleate or palmitate in 24 well plates were fixed with 10% formalin for 10mins 
followed by PBS wash. Staining with a working solution of oil red O for 15mins (4ml 
distilled water+6ml stock oil red O solution). The stock solution was prepared by 
dissolving  0.5g of oil red O in 100 ml of 99% isopropanol. After staining, the plates were 
washed with distilled water three times and mounted with coverslips. Images were 
acquired using EVOS FL Auto Cell Imaging System. 
Statistical analysis: Analysis of variance (ANOVA) with post-hoc Bonferroni 
corrections was employed for comparisons of multiple groups. P value <0.05 was 
considered statistically significant. 
4.4 Results 
 
Palmitoleate treatment (200µM) in ZIKV infected JEG-3 cells results in attenuation 
of pro-inflammatory cytokine IL-1β: JEG-3 infected with 0.1 MOI r-MRV treated 
either with palmitoleate or palmitate treatment for 48 hpi were used to measure mRNA 
levels of IL-1β. We saw that IL-1β mRNA expression levels in 200µM palmitoleate 
treated cells after ZIKV infection was significantly downregulated when compared to 
ZIKV infected cells treated with 100µM palmitoleate and ZIKV infected cells alone 





3 cells attenuates pro-inflammatory cytokine IL-1β expression in response to viral 
infection. 
 
Fig.4. 1.Palmitoleate (200µM) treatment in ZIKV infected JEG-3 cells results in 
attenuation of pro-inflammatory cytokine IL-1β.   
JEG-3 cells infected with 0.1 MOI r-MRV were treated with 100-200µM palmitoleate for 
48h. ZIKV infected JEG-3 cells with 200µM palmitoleate supplementation showed a 
significant reduction in the IL-1β mRNA expression when compared to infected cells 
alone and ZIKV infected cells treated with 100µM palmitoleate. Uninfected vehicle cells 
showed a ct value of N/A or less than 32. Data represent ± SEM, n=3, * P<0.05 
compared to ZIKV infected cells, statistical comparison by ANOVA with post hoc 
Bonferroni correction. 
 
Palmitoleate increases lipid droplet accumulation and decreases viral E protein 





with either palmitoleate or palmitic acid. After 48 h of infection expression of both viral 
E protein and ADRP ( biomarker for lipid droplets) were analyzed by 
immunofluorescence. Uninfected vehicle cells showed no ZIKV E protein expression 
along with little ADRP staining (Fig.4.2A). ZIKV infected cells showed intense viral E 
protein staining whereas little ADRP staining compared to vehicle cells (Fig.4.2B). JEG-
3 cells treated with 100µM palmitoleate 48hpi showed both viral E protein sating as well 
as ADRP staining (Fig.4.2C). Interestingly, ADRP staining was seen in healthy cells 
without viral E protein expression. While JEG-3 cells treated with 200µM palmitoleate 
48hpi showed high levels of ADRP expression and very low levels of viral E protein 
expression compared to ZIKV infected cells alone (Fig.4.2D). JEG-3 cells treated with 
100µM palmitate 48hpi showed intense viral E protein staining and low ADRP staining 
(Fig.4.2E). ZIKV infected cells when co-treated with 200µM palmitate showed lesser 
viral E protein staining intensity when compared to 100 µM palmitate along with low 










Fig.4. 2.Palmitoleate increases lipid droplet accumulation and decreases viral E 
protein expression in JEG-3 cells.  
Representative images from immunofluorescence analysis with DAPI (blue), ZIKV E 
protein (green), ADRP (red) and merge panels respectively (A) Vehicle: Uninfected JEG-
3 cells showed neither viral E protein expression nor lipid droplet accumulation. (B) r-
MRV: JEG-3 cells infected with 0.1 r-MRV for 48h showed ZIKV E protein expression. 
(C)  r-MRV+100 PO: JEG-3 treated with 100µM palmitoleate for 48hpi showed cells 
with ZIKV E protein expression and cells without viral E protein expression showed lipid 
droplet accumulation. (D)  r-MRV+200 PO: JEG-3 treated with 200µM palmitoleate for 
48hpi showed dramatic accumulation of lipid droplets along with very low levels of viral 
E protein expression. (E-F) r-MRV+100 PA, r-MRV+200 PA: JEG-3 cells treated with 
100-200µM palmitate for 48hpi showed viral E protein expression coupled with very low 
levels of lipid droplet formation. 
 
Lipid droplet staining in ZIKV infected JEG-3 cells using oil red O staining: Lipid 
droplets were stained with oil red O in r-MRV (0.1 MOI) infected JEG-3 cells co-treated 
with either palmitoleate or palmitate for 48 h. Very low levels of lipid droplets were 
noticed in uninfected vehicle cells (Fig.4.3A) whereas ZIKV infected cells showed lipid 
droplets concentrated in the healthy cells surrounding areas that showed cytopathic effect 
as shown in Fig.4.3B. Both 100 and 200µM palmitoleate treatment in ZIKV infected 
cells showed cells with extensive lipid droplet accumulation but the level of lipid droplet 
accumulation was higher in 200µM palmitoleate treated cells when compared to 100µM 
of palmitoleate supplementation (Fig.4.3C-D). Treatment of 100-200µM palmitate for 
48h in ZIKV infected cells showed decreased lipid droplets as well as a decreased 
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Fig.4. 3.Lipid droplet staining in ZIKV infected JEG-3 cells using oil red O staining.  
E   r-MRV +100 PA 





Representative images after oil red O staining showing lipid droplets (A) Vehicle: 
Uninfected JEG-3 cells showed little or no lipid droplet accumulation. (B) r-MRV: JEG-3 
cells infected with 0.1 r-MRV for 48h showed lipid droplet accumulation in the cells 
surrounding the infected area with cytopathic effect as shown with the arrow mark. (C)  r-
MRV+100 PO: JEG-3 treated with 100µM palmitoleate for 48hpi showed infected cells 
showed healthy cells with lipid droplet accumulation. (D)  r-MRV+200 PO: JEG-3 
treated with 200µM palmitoleate for 48hpi showed dramatic accumulation of lipid 
droplets along with a lawn of healthy cells (E-F) r-MRV+100-200µM  PA: JEG-3 treated 
with 100-200µM palmitate for 48hpi showed fewer cells and less lipid staining when 
compared to ZIKV infected cells treated with palmitoleate. 
 
4.5 Discussion 
In this present study, the findings are: 1) Palmitoleate at 200µM concentration was able 
to reduce ZIKV viral E protein expression along with high lipid droplet accumulation 2) 
Oil red O staining also revealed higher lipid droplet accumulation in palmitoleate treated 
ZIKV infected trophoblasts when compared to palmitate treated ZIKV infected cells or 
ZIKV infected cells alone 3) palmitoleate treatment (200µM) significantly reduced IL-1β 
mRNA expression when compared to ZIKV infected cells alone.  
ZIKV is known to disrupt the placental barrier and inflammation (15,16). ZIKV can 
increase the expression of prostaglandins associated with inflammation and 5-oxo-
eicosatetraenoic, an arachidonic acid metabolite in the human placenta (3). ZIKV causes 
considerable alterations in the host lipid metabolism (3) in particular sphingolipids are 
crucial for ZIKV replication (17).  
Lipid droplets apart from their conventional role of lipid storage facilitation, it is also 
important in innate immune signaling responses of the body (18). In our investigation of 
JEG-3 cells, we found that palmitoleate treatment to ZIKV infected cells resulted in 





suggests that palmitoleate could play an important protective role in activating innate 
immune signaling which could decrease viral E protein production. ZIKV has known to 
cause alterations in lipid droplets and utilize them to for their replication (18). We also 
noticed similar phenomena where lipid droplets were concentrated in ZIKV infected 
JEG-3 cells surrounding the areas showing cytopathic effect. Another study showed that 
ZIKV reduces the number of lipid droplets in infected Huh-7 cells (human hepatoma cell 
line) when compared to uninfected cells (18).  In our study, we found that palmitoleate 
treatment for 48h in ZIKV infected cells increased lipid droplet accumulation and 
reduced viral E protein expression. This might be probably because the lipids trapped in 
the form of droplets in palmitoleate treated cells may not readily available for ZIKV to 
utilize for its effective replication. Lipid droplets are also known to be a protective 
mechanism by the host against viral infections (13).  
We also noticed that IL-1β mRNA expression was significantly downregulated in 200µM 
palmitoleate treated JEG-3 cells infected with 0.1 MOI r-MRV. Studies have shown that 
palmitoleate has promising anti-inflammatory properties in human endothelial cells and 
high-fat diet-induced hepatitis (19,20).  Decreased number of cells with palmitate 
supplementation in ZIKV infected cells can be related to cell death data from previous 
chapters. Palmitate is also known to produce an inflammatory cytokine profile in the 
placenta (21).  
Altogether, palmitoleate treatment in ZIKV infected trophoblasts results in lipid droplet 





causes IL-1β secretion by NLRP3 inflammasome activation (22), palmitoleate 
supplementation might also alleviate inflammasome activation in ZIKV infected cells. 
4.6 Conclusion 
Palmitoleate supplementation in ZIKV infected trophoblasts has a potential anti-
inflammatory effect by increasing the formation of protective lipid droplets impeding 
viral replication and innate immune signaling. 
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CHAPTER 5: SUMMARY 
 
We confirmed that ZIKV infection with 0.1-1 MOI to JEG-3, JAR and HTR-8 cells 
induces apoptosis. Next, we demonstrated the activation of ER stress markers in ZIKV 
infected trophoblasts and found that ZIKV infection increases splicing of the XBP1 
mRNA and phosphorylation of both eiF2α and IRE1α. Further, CHOP, an ER stress 
biomarker and a critical mediator of apoptosis was found to translocate to the nucleus in 
ZIKV infected trophoblasts. In addition, JNK and p38 MAPK kinases were found to be 
activated via phosphorylation in JEG-3, JAR and HTR-8 cells. By using small-molecule 
inhibitors we have demonstrated that JNK activation is a key mediator in driving the 
ZIKV-induced trophoblast apoptosis. 
Next, with the knowledge of the involvement of ER stress and apoptosis in ZIKV 
infected trophoblasts, we wanted to use a safe and protective nutrient compound that 
could control or prevent ZIKV spread from the infected mother to the fetus via 
transplacental route. We chose to use palmitoleate, an omega 7 monounsaturated fatty 
acid based on its cytoprotective effect against free fatty acid-induced apoptosis. We 
treated trophoblasts (JEG-3, JAR and HTR-8 cells) with 100-200uM palmitoleate after 
virus adsorption and found a reduction in the percent apoptotic nuclei and inhibition of 
caspase 3/7 activity, 48-72h post-infection. Further treatment of palmitoleate to ZIKV 
infected trophoblasts showed decreased viral E gene in the cell culture supernatant and 
cell lysate was reduced when compared to infected cells. To compare this unique 





infection and found that palmitic acid did not protect against ZIKV-induced apoptosis. 
Conversely, treatment of 200uM palmitoleate significantly downregulated CHOP 
expression and XBP1 gene splicing. Even though palmitic acid-treated trophoblast 
supernatant had less viral titer pfu/mL, still the cell viability was considerably lower 
when compared to palmitoleate treated ZIKV infected cells. Taken together, from in vitro 
studies using trophoblasts, we found that palmitoleate treatment attenuates ZIKV-induced 
trophoblast apoptosis and improves cell viability with reduced viral load. We also noticed 
extensive lipid droplet accumulation accompanied with significant attenuation of IL-1β 
pro-inflammatory cytokine mRNA expression in 200µM palmitoleate treated JEG-3 cells 
48hpi. Overall, palmitoleate treatment protects aganinst ZIKV infection-induced ER 


















CHAPTER 6: FUTURE DIRECTIONS 
 
To further investigate the mechanism behind palmitoleate protection against ZIKV-
induced apoptosis in trophoblasts, a transcription factor, PPARα can be studied as it is 
known to be involved in the positive metabolic effects induced by palmitoleate 
supplementation. Metabolic targets like phosphorylation of AMPK can also be studied as 
they are involved in the action of catabolic pathways including fatty acid β-oxidation for 
energy generation. Additionally studying ZIKV infection and palmitoleate treatment in 
Muller glial cells of the retina and testicular cells can also give some new insights. 
 Immunodeficient IFNR1+/- mice or immunocompetent mice with human STAT2 gene 
knock-in, which can be infected with Rag1-/- mouse-adapted ZIKV strain can be used to 
study the protective effect of palmitoleate against the transplacental route of infection 
from the dam to the developing pups. Apart from mice models, studies in human primary 
trophoblasts isolated from term placental are also required to establish the protective role 
of palmitoleate against ZIKV infection. 
In our preliminary studies, we have observed downregulation of IL-1β expression with 
200µM palmitoleate treatment in ZIKV-infected cells when compared to ZIKV-infected 
trophoblasts alone. Investigating innate immunity pathways including NLRP3 
inflammasome activation in ZIKV infected trophoblasts and the role of palmitoleate in 
modulating the response can also provide useful information.  
